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Introduction In 2002, the Surviving Sepsis Campaign defi  ned a strategy that 
aimed to reduce the high mortality due to sepsis. One point of this strategy 
was a recommendation to recognize that sepsis is a frequent cause of death 
and high economic costs in the pediatric intensive care unit. Knowledge of 
the disease is the fi  rst step to impact it. There are few studies on pediatric 
sepsis epidemiology in the world and none in Colombia.
Hypothesis The epidemiological features of Colombian children are diff  erent 
from other countries.
Methods We constructed a website where 14 intensive care units across the 
country reported in a prospective way the epidemiological features of children 
with sepsis using an electronic process [1]. We asked for sociodemographics, 
microbiological data, sepsis classifi  cation, complications, and outcome.
Results We collected 253 patients from March to May 2009.Fifty-fi  ve percent 
of the cases were male and 45% were female; 53% were less than 1 year old. 
A total of 67.2% came from urban areas and 33% came from rural villages. 
Eighty-fi  ve percent were very poor (score 1 and 2 over 6 used in Colombia 
as socioeconomic classifi  cation).  Forty-fi   ve percent have government-
supported insurance. In total, 23.72% of the population presented with 
sepsis; 30.04% with severe sepsis; and 46.5% with septic shock. The infection 
origin was respiratory in 54.55%, followed by abdominal in 17.39%. In 50.2% 
no cause was identifi  ed. A total of 75.1% required mechanical ventilation. 
The mortality rate was 20.4%.
Conclusions Sepsis, severe sepsis, or septic shock is a common diagnosis in 
Colombian intensive care units. The majority of pediatric patients are 2 years 
or younger and from the poorest communities. It aff  ected males more. In 
the majority, the process starts in the respiratory system. We had diffi   culty 
identifying the cause. The disease causes high mortality and cost for a 
developing society. We need a complete survey to fi  nd a correct approach 
to the problem.
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Introduction  Hydroxyethyl starch (HES) is widely used for volume 
therapy in intensive care. In critically ill and sepsis patients, HES use was 
dose-dependently associated with increased renal failure, tissue storage 
with organ failure, and increased long-term mortality. There are other safety 
concerns with regard to coagulopathy, pruritus, and mortality. However, 
third-generation HES 130/0.4 is considered to have an improved risk profi  le. 
Therefore, we wanted to assess whether published studies on HES 130/0.4 
resuscitation are suffi   ciently well designed to draw conclusions about the 
safety of this compound.
Methods We derived clinically relevant outcome parameters to analyze safety 
outcomes from the literature and provided exemplary power calculations. 
Randomized controlled trials (RCT) on fl  uid resuscitation with HES 130/0.4 
were systematically searched and analyzed for clinical condition, sample 
size, study duration, cumulative dose, control fl  uids, endpoints, and colloid–
crystalloid volume ratios in studies with a goal-directed fl  uid regimen. Due to 
the heterogeneity of included studies, all analyses were descriptive (SPSS 17.0).
Results A total of 56 RCTs were included. Only two studies included severe 
sepsis patients, 80% were from the elective surgical setting and one study 
from the emergency surgical setting. In general, studies were underpowered 
(median sample size 25 patients in HES 130/0.4 groups, range 10 to 90 
patients); of short duration (median study period 12 hours, range 0.5 to 144 
hours) and with low cumulative HES doses (median 2,465 ml, range 328 to 
6,229 ml). Sepsis studies (n = 2) included 18 patients (median, range 10 to 
26 patients), study period was 96 hours (median, range 72 to 120 hours) 
and total fl  uid volumes was 3,000 ml in one study. Sixty percent of control 
fl  uids were synthetic colloids (other starches, gelatins, or dextran) that carry 
a similar risk profi  le. Primary endpoints with power calculation (in 87% of 
studies) were mostly unspecifi  c or clinically irrelevant. Only one sepsis study 
provided a primary endpoint, which was extravascular lung water. This did 
not diff  er in comparison with the albumin 20% control group.
Conclusions There is no reliable evidence from published clinical data that 
third-generation HES 130/0.4 is safe in septic patients or in the emergency or 
elective surgical setting.
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Introduction Unregulated elevated levels of serum TNFα have been asso-
ciated with proinfl  ammatory cytokine cascades, which are characteristic 
in diseases such as septic shock. Endotoxic shock, which has a poorer 
prognosis than found with other forms of septic shock, is mediated by 
lipopolysaccharide (LPS), a molecule that is released from the outer 
membrane of Gram-negative bacteria. LPS is a potent stimulator of TNFα 
secretion by serum monocytes and tissue macrophages. While the use 
of monotherapeutic TNFα antagonists has been trailed, none has been 
registered for use in patients with sepsis.
Objective  The purpose of this study was to test the eff   ect of canine 
hyperimmune frozen plasma (HFP), which is known to contain elevated 
levels of soluble TNFα receptor 1 (sTNFR1), on TNFα and infl  ammatory cell 
levels in a LPS-mediated rat air pouch model of infl  ammation.
Methods A dorsal air pouch in 175 to 200 g Sprague–Dawley rats was formed 
by 20 ml subcutaneous infusions of sterile air. Prophylactic subcutaneous 
injections of canine HFP, canine fresh-frozen plasma (FFP), or carprofen  © 2010 BioMed Central Ltd
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© 2010 BioMed Central Ltdwere administered daily for 3 days into the lateral fl  ank of the right foreleg 
at doses recommended by the manufacturers (n = 10 for each treatment 
group). Pouch fl  uid was harvested by syringe at 1, 6, 12, 24, and 48 hours 
post LPS administration and subjected to histological and cytokine/cytokine 
receptor analysis. TNFα and sTNFR1 levels were determined by ELISA and an 
immunofl  uorescent dot blot assay.
Results Pouch fl  uid analysis: maximal eff  ects were detected at 6 hours post 
LPS administration. TNFα levels were signifi   cantly depressed in animals 
dosed with HFP, but not in animals treated with FFP or carprofen (P <0.05). 
sTNFR1 levels were signifi  cantly elevated in HFP, but not in FFP or carprofen-
dosed animals (P <0.05). Neutrophil numbers were signifi  cantly depressed 
in HFP-dosed, but not in FFP-treated or carprofen-treated animals (P <0.05).
Conclusions There appears to be a correlation between elevated levels of 
sTNFR1 and depression of TNFα and neutrophil levels in the pouch fl  uid 
of HFP-dosed rats (r  =  –0.73,  P  <0.0001). The data suggest that canine 
HFP, which has been demonstrated to contain elevated levels of sTNFR1 
compared with FFP, has a direct eff   ect on depressing TNFα levels and 
neutrophil sequestration in the rat air pouch model of infl  ammation. These 
data suggest that HFP may be worthy of further investigation to determine 
whether such preparations have a therapeutic potential for treatment of 
acute infl  ammatory diseases in which TNFα is implicated.
P4
Development of Klebsiella pneumoniae B5055-induced mouse model of 
sepsis-associated brain infl  ammation in BALB/c mice
V Kumar1, A Sharma2
1Dr Y. S. Parmar University, Microbiology, Himachal Pardesh, India; 2Saint-Justine 
Hospital, University de Montreal, Medicine, Montreal, Canada
Critical Care 2010, 14(Suppl 2):P4 (doi: 10.1186/cc9107)
Introduction  Incidence of sepsis is continuously increasing in the 
developing as well as the developed world. Severe sepsis is associated with 
the development of multiorgan dysfunction syndrome. In addition to other 
vital organs (that is, lungs, kidneys, heart, or liver), the brain is one of the 
severely aff  ected organs in sepsis. Autopsy studies from septic patients reveal 
various cerebral lesions including ischemia, hemorrhage, microthrombi, 
microabscesses, multifocal necrotizing leukoencephalopathy, and bacterial 
invasion of the nervous system. Until now no animal model of sepsis has 
been developed that in a true sense represents the brain infl  ammation 
associated with evolving sepsis originating from Gram-negative bacteria. 
This study comprises development of a mouse model of sepsis-induced 
brain infl  ammation.
Methods  A mouse model of sepsis-associated brain infl  ammation  was 
developed by directly placing a selected dose (102 cfu) of Klebsiella 
pneumoniae B5055 entrapped in a fi  brin–thrombin clot into the peritoneal 
cavity of mice, while in control group animals only a sterile fi  brin clot was 
kept. Various infl  ammatory cytokines (that is, IL-1α and TNFα) and other 
infl  ammatory markers (that is, malondialdehyde, myeloperoxidase and nitric 
oxide) in serum and brain were estimated by ELISA, biochemical methods, 
and histopathology in both the experimental groups.
Results Bacterial colonies were found to be established in brain on the very 
fi  rst day of sepsis induction in experimental group but no bacteria were 
observed in sham-operated animals. Along with this, a signifi  cant (P <0.05) 
increase in neutrophil infi  ltration into the brain along with signifi  cantly 
(P <0.05) increased levels of proinfl  ammatory cytokines (TNFα and IL-1α) 
and other infl  ammatory mediators like nitric oxide, malondialdehyde, and 
myeloperoxidase were observed in animals with sepsis. Also the septic 
animals survived until the 5th day of post-sepsis development, while 100% 
survival was observed in the sham-operated group on all experimental 
days without any infl   ammatory change in the brain as observed by 
histopathologic examination and estimating the above-mentioned 
infl  ammatory parameters.
Conclusions This mouse model of sepsis-induced brain infl  ammation may 
prove helpful to study immunopathogenesis of brain infl  ammation observed 
during Gram-negative bacterial sepsis and may also prove helpful to study 
neuroimmunology of sepsis along with behavioral changes associated with 
sepsis.
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Introduction  Extracorporeal hemoperfusion with polymyxin B is a novel 
septic treatment, shown to improve hemodynamics, organ dysfunction, 
and mortality through the removal of circulating lipopolysaccharide (LPS). 
This therapy can also remove activated leukocytes, which likely contributes 
to reduced infl   ammation and improved patient outcome; however, the 
mechanistic role of LPS in the removal of leukocytes remains unclear.
Objective To determine whether the presence of LPS and/or activation of 
leukocytes by LPS alters their ability to bind to polymyxin-bound fi  lters used 
for extracorporeal hemoperfusion of septic patients.
Methods Toraymyxin® fi  lters were opened under sterile conditions and 2 cm2 
sections were incubated for 2 hours under various conditions. Experi  ment 
1: fi  lters were exposed to (1) whole blood collected from a health volunteer, 
(2)  blood with 700  ng/ml LPS (Escherichia coli 0127:B8), or (3) blood pre-
incubated for 2 hours in 700 ng/ml LPS. Experiment 2: fi  lters were pre-exposed 
to LPS then incubated with blood alone or blood with LPS. Experiment 3: fi  lters 
were exposed to blood containing increasing LPS concentrations (1 pg/ml 
to 500 ng/ml) or TNFα (15 pg/ml to 10 ng/ml). In all experiments, following 
incubation, fi  lters were washed, stained (methylene blue + eosin) and the 
number of adhered leukocytes were counted by light microscopy. Endotoxin 
activity of the collected whole blood in both the absence and presence of LPS 
was determined by an endotoxin activity assay (EAA™).
Results  The presence of LPS signifi   cantly increased (3.77  ±  0.54-fold, 
P = 0.005) the number of adhered leukocytes to Toraymyxin® fi  lters. Moreover, 
pre-incubation of the blood with LPS, to activate infl  ammatory cells, further 
increased leukocyte adhesion (7.59 ± 1.08-fold increase vs. control, P = 0.002, 
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S2or vs. non-incubated LPS, P = 0.03). Pre-exposure of Toraymyxin® fi  lters to 
LPS versus vehicle control increased leukocyte adhesion, both for blood 
alone (7.60 ± 1.51-fold increase, P = 0.004) or blood incubated with LPS 
(24.43 ± 5.32-fols vs. 7.59 ± 1.08-fold increase, P = 0.019). Moreover, while 
the presence of TNFα or low levels of LPS did not induce leukocyte binding 
to Toraymyxin® fi   lters, increasing LPS concentrations induced a dose-
dependent increase in adhesion (Figure 1). Sterile blood was confi  rmed by 
EAA to have low endotoxin activity (EAA™ <0.3), while blood containing 
700 ng/ml LPS had high endotoxin activity (EAA™ = 0.8).
Conclusions While leukocyte activation by LPS increases their adhesion to 
Toraymyxin® fi  lters, the activation of leukocytes by TNF did not alter binding, 
indicating the essential need for the presence of LPS possibly as a bridging 
molecule in the mechanism responsible for the removal of leukocytes during 
extracorporeal hemoperfusion with Toraymyxin® fi  lters.
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Introduction  The triad interaction of neonatal–maternal–bacterial deter-
minants plays a crucial role in the increased incidence of bacterial sepsis 
during the neonatal period. This study was undertaken to determine whether 
neonatal–maternal predisposing factors and bacterial pathogens aff  ect the 
risk of early or late onset sepsis.
Methods Three hundred neonates in the NICU of two hospitals in Tehran 
were studied. Blood cultures from neonates with suspected sepsis were 
performed on BHI broth followed by identifi  cation of isolates and testing 
for their susceptibility to antimicrobial agents. Collectively, neonatal and 
maternal risk factors such as birth weight, gestation age, PROM, Apgar score, 
and others were studied in the cultures of proven cases of neonatal sepsis. 
In univariate binary logistic regression models, the impact of neonatal and 
maternal factors on sepsis risk was estimated in terms of odds ratio (OR) with 
95% confi  dence interval (CI).
Results The present study revealed the impact of bacterial pathogens and 
neonatal and maternal predisposing factors on sepsis as follows. Bacterial 
pathogens:  14/300 (4.7%) of neonates developed septicemia. Among 
infected neonates, 64.3% and 35.7% were considered with early-onset and 
late-onset sepsis, respectively. The most isolated Gram-negative organism 
was Stenotrophomonas maltophilia (42.8%) followed by Klebsiella pneumonia 
(28.6%),  Escherichia coli (21.4%) and Serratia liquefaciens (7.2%).  Neonatal 
factors: the mean age of neonates ± SD with early-onset sepsis (1.56 ± 0.88) 
was lower than that of those with late-onset sepsis (10.40  ±  5.50) and 
this diff   erence was statistically signifi  cant  (P  <0.05). Low birth weight 
(LBW) <2,500 g increased the risk of sepsis to more than twofold (OR = 2.9, 
95% CI = 1.17 to 9.86; P <0.01). Gestation age (GA) <29 weeks was signifi  cantly 
associated with sepsis (P <0.01). The septicemia, in turn, increased the risk of 
death up to more than fi  vefold (OR = 5.5; 95% CI = 1.98 to 15.3; P <0.01). 
More than one-half of septic neonates had positive result for CRP whereas 
only 1.9% of neonates with sepsis were CRP-negative, and this diff  erence was 
statistically signifi  cant (P <0.001). Maternal factors: PROM aff  ected the sepsis 
risk to more than threefold (OR = 3.8; 95% CI = 1.37 to 10.56; P <0.05).
Conclusions The present study reveals that specifi  c neonatal and maternal 
factors are associated with increased risk of sepsis. Among the studied factors, 
prematurity of neonates explained as GA and LBW are the most important 
contributors to morbidity in neonate who suff  ered from sepsis. Furthermore, 
PROM as a maternal risk factor predisposes a child to neonatal sepsis.
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Introduction Mortality from sepsis is greater in the elderly than in the young 
although incidence only increases slightly. Pulmonary infections caused by 
Staphylococcus aureus that progress into sepsis are a major cause of death 
in elderly patients. Bacterial pneumonia is a common precipitating cause 
of sepsis. Gram-positive bacteria are increasing as causative agents of 
pneumonia in the elderly.
Objective  To investigate age-dependent changes in the intrapulmonary 
response to staphylococcal challenge.
Methods Cell wall components lipoteichoic acid (LTA, 200 ng) and peptido-
glycan (PGN, 660 ng) from S. aureus were instilled intratracheally to young (3 to 
4 months) and old (>18 months) C57Bl6 mice (n >5/group). Controls received 
saline alone. After 6 hours, mice were euthanized by exsanguination, and 
blood saved for analysis. One-sided lavage was performed, the nonlavaged 
lung tissue collected and total RNA isolated.
Results  Using this relatively mild challenge of LTA and PGN, we observed 
signifi   cant and age-dependent diff   erences in the infl  ammatory  response. 
Macrophage migration inhibitory factor (MIF) protein was signifi  cantly and age-
dependently increased in BAL and plasma. A trend toward lower levels of total 
cells and neutrophils in the lung was noted in the old following stimulation, 
although the variation of the response was large. The dynamics of MIF at a 
transcriptional level in the lung was age-dependently altered, with a marked 
downregulation in the young mice after stimulation, whereas levels of MIF 
mRNA remained unchanged in the old mice. Transcriptional changes were also 
noted for the anti-infl  ammatory cytokine IL-10 and other mediators involved in 
lymphocyte, macrophage and neutrophil recruitment. Interestingly, explanted 
lung cells from young and old mice showed a similar expressional pattern, with 
atypical expression levels in cells originating from old mice lungs.
Conclusions  The fi  ndings support a hyperinfl  ammatory response in the 
older individual at the measured time point. Interestingly, the diff  erences 
were sustained in vitro in cells explanted from young and old mice. Together 
the data suggest an altered infl  ammatory response to infectious challenge 
of the aged lung. Explanted cells from old animals may be a valuable tool 
in determining age-dependent diff  erences in infl  ammatory response and 
identifying novel targets for intervention.
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Introduction  Sepsis is a complex immunological response to infection 
characterized by a sinusoidal pattern that represents early hyperinfl  ammatory 
Figure 1 (abstract P6). *, **, *** = versus all other groups, P <0.05.
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S3signals [1] followed by severe and protracted immunosuppression, 
suggesting that a multimarker approach has the greatest clinical utility in 
early detection within a clinical environment focused on SIRS diff  erentiation. 
Preclinical research using an equine endotoxemia model identifi  ed a panel 
of gene expression biomarkers that defi  ne the aberrant immune activity 
during early sepsis. Thus, the primary objective was to apply these gene 
expression biomarkers to distinguish patients with sepsis from those who 
had undergone major open surgery and had clinical outcomes consistent 
with systemic infl  ammation due to physical trauma and wound healing.
Methods This was a multicenter, prospective clinical trial conducted across 
four tertiary critical care settings in Australia. Sepsis patients were recruited 
if they met the 1992 Consensus Statement [2] and had clinical evidence of 
systemic infection based on microbiology diagnoses (n = 27). Participants 
in the post-surgical (PS) group were recruited preoperatively and blood 
samples collected within 24 hours following surgery (n = 36). Healthy controls 
(HC) included hospital staff   with no known concurrent illnesses (n = 19). Each 
participant had minimally 5 ml PAXgene blood collected for RNA isolation 
and gene expression analyses. Aff  ymetrix Exon array and multiplex tandem 
(MT)-PCR studies were conducted to evaluate gene expression using a set of 
molecular markers that had been identifi  ed a priori. A LogitBoost algorithm 
was used to create a machine-learning diagnostic rule in which to predict 
sepsis outcomes.
Results Based on preliminary exon array analyses comparing HC and sepsis 
groups, a panel of 42 gene expression markers was identifi  ed that linked 
to key innate immunity, cell cycle, endothelial, coagulation, and apoptotic 
pathways. When sepsis and PS groups were combined, the test had an ROC 
area >95%. Using subsets of these biomarkers in the MT-PCR assay, the ROC 
AUC for sepsis prediction was between 85 and 90%.
Conclusions This novel molecular biomarker test has a clinically relevant 
sensitivity and specifi  city profi  le, and has the capacity for early detection of 
sepsis via the monitoring of critical care patients.
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Introduction  Nitric oxide (NO) plays a key role in innate immune 
system controlling microbial infection; however, during septic shock its 
exacerbate formation is associated with several deleterious complications. 
Cholecystokinin (CCK) was fi  rst described as a gastrointestinal hormone, 
but immune cells express their receptor, suggesting a possible involvement 
of this hormone in modulation of infl  ammatory response. Our aim was to 
evaluate the role of CCK on NO production during endotoxemia in rats as 
well as lipopolysaccharide (LPS)-stimulated macrophages.
Methods Male Wistar rats received an intravenous injection of CCK (0.4 and 
40 μg/kg) 10 minutes before LPS (1.5 mg/kg) administration. The mean 
arterial pressure was monitored during 6 hours after endotoxin injection. 
Blood was collected for plasma nitrate level and vasopressin measurement at 
2, 4 and 6 hours after LPS. Thioglicollate-elicited macrophages were obtained 
by peritoneal lavage and cultured in RPMI 1640 medium, supplemented with 
10% fetal bovine serum and antibiotics. Macrophage culture was treated 
with CCK (10–14, 10–12, 10–10, 10–8, 10–6 M) 30 minutes before LPS stimulation 
(1 μg/ml) and supernatant nitrite concentration was determined at 6, 24 and 
48 hours. The iNOS expression was evaluated by quantitative real-time PCR 
and the amount of gene transcription was measured using the delta–delta 
method. The presence of iNOS was analyzed by indirect immunofl  uorescence 
at 12 and 24 hours after LPS incubation.
Results The LPS-induced hypotension was reverted by the pretreatment 
with CCK only at the lower dose. Moreover, CCK increased vasopressin levels 
at 2 and 4 hours after LPS administration and reduced nitrate levels during 
2 and 6 hours. LPS-stimulated macrophages increased rapidly nitrite levels 
in supernatant and also iNOS expression. The pretreatment with CCK at all 
tested concentrations signifi  cantly reduced nitrite levels at 6, 24 and 48 
hours after LPS stimulation when compared with the LPS group (P <0.05). The 
iNOS/GAPDH expression ratio were also lower in CCK-treated cells at 6 and 
24 hours (P <0.001). The qualitative analysis of iNOS protein was assessed at 
12 and 24 hours after LPS stimulus by immunocytochemistry. In CCK-treated 
macrophages, a reduction of fl  uorescence emission in comparison with the 
LPS group was observed. In control groups (without LPS), fl  uorescence was 
not observed, suggesting the absence of iNOS protein in non-infl  ammatory 
conditions.
Conclusions These data suggest that CCK restores hypotension and reduces 
NO formation during endotoxemia in rats. Furthermore, CCK regulates 
negatively iNOS expression and also NO synthesis in LPS-activated peritoneal 
macrophage culture.
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Introduction  Mitochondrial dysfunction has been suggested as a 
contributing factor in the pathogenesis of multiple organ dysfunction 
syndrome (MODS) and sepsis is the leading cause of MODS. Also, restoration 
of mitochondrial function, known as mitochondrial biogenesis, has been 
implicated as a key factor for the recovery of organ function in patients with 
sepsis. Here we investigated platelet mitochondrial respiratory function in 
patients with sepsis during the fi  rst week after disease onset.
Methods Platelets were isolated from blood samples taken from 18 patients 
with severe sepsis or septic shock within 48 hours of their admission to the 
intensive care unit. Subsequent samples were taken on days 3 to 4 and days 6 
to 7. Eighteen healthy blood donors served as controls. Platelet mitochondrial 
function was determined by high-resolution respirometry. Endogenous 
respiration of intact platelets suspended in their own plasma or PBS glucose 
was determined and, in order to investigate the activity of individual complexes 
of the respiratory system, platelets were permeabilized with digitonin and 
stimulated with complex-specifi  c substrates and inhibitors.
Results There was a signifi  cant increase in maximal respiratory capacity of 
platelets from days 1 to 2 to days 6 to 7 as well as compared with controls in 
both intact platelets and permeabilized platelets oxidizing complex I and/or 
II linked substrates. Platelets suspended in their own septic plasma exhibited 
increased leak respiration compared with platelets suspended in PBS glucose 
and to controls. No inhibition of respiration was detected in septic patients 
compared with controls. Mortality at 90 days was 33% (6/18). Nonsurvivors 
had a signifi  cantly more elevated respiratory capacity at days 6 to 7 as 
compared with survivors. No correlation between respiratory capacity and 
severity of disease as measured by APACHE II, SAPS II, SOFA or noradrenaline 
dose were found. Platelet content of mitochondria-specifi  c cytochrome c 
increased signifi  cantly, but no change in mitochondrial DNA was detected 
over the time interval studied.
Conclusions The results indicate the presence of a soluble plasma factor in the 
initial stage of sepsis inducing uncoupling of platelet mitochondria but not 
inhibition of oxidative phosphorylation. Further, the mitochondrial uncoupling 
was paralleled by a gradual and substantial increase in respiratory capacity that 
may refl  ect mitochondrial biogenesis as a response to severe sepsis or septic 
shock. The enhanced respiratory capacity developing over the fi  rst week seems 
to refl  ect the severity of the condition and may be used as a prognostic marker 
of mortality.
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Introduction  The endotoxin activity assay (EAA) is a rapid whole-blood 
chemiluminescent test for endotoxin that has proven clinical utility in the 
detection and risk stratifi  cation of clinically ill patients with suspicion of 
sepsis.
Methods The EAA was studied in a cohort of 153 septic patients admitted to 
the ICU. At the same time, IL-6 (chemiluminescent enzyme immunoassay), 
C-reactive protein (CRP), procalcitonin (PCT, chemiluminescent enzyme 
immunoassay) and plasminogen activator inhibitor-1 (PAI-1, latex 
photometric immunoassay) were measured within 24 hours after ICU 
admission. The patients were divided into the following three groups: L 
group: EAA <0.4, M group: 0.4 ≤EAA <0.6, H group: 0.6 ≤EAA. Nonrepeated-
measures ANOVA was used to compare over three groups or conditions. 
Statistical signifi   cance was assumed for values of P  <0.05. Normally 
distributed data are presented as mean ± SD, and abnormally distributed 
data are presented as median values.
Results Of the 153 patients, the L group contained 61 patients, M group 41 
patients, and H group 51 patients, respectively. On the day of ICU admission, 
the rate of EAA ≥0.4 was 60.1% (MEDIC study: 57.2%). APACHE score in the 
L group was 21.0 ± 7.9, M group 24.8 ± 8.4, H group 26.4 ± 8.9, and SOFA 
score in the L group was 8.2 ± 4.3, M group 8.9 ± 4.1, H group 9.5 ± 4.3, 
respectively. There was no statistically signifi  cant  diff   erence among the 
groups. The median value of PCT in the L group was 1.1 ng/ml, M group 
5.9 ng/ml, H group 8.5 ng/ml, respectively. PCT values of the M and H groups 
were signifi  cantly higher than those of the L group. Median IL-6 level of the 
H group was signifi  cantly higher than that of the L group (H group: 2,635 pg/
ml, L group: 177 pg/ml).
Conclusions  EAA has no signifi  cant correlation with other sepsis-related 
markers, but may be associated with body insults (infl  ammation or infection).
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Introduction Severe sepsis occurs frequently in the ICU and is a leading cause 
of admission, mortality, and cost. Management guidelines defi  ne treatment 
objectives within the fi  rst 6 hours of clinical syndrome presentation. However, 
blood culture test confi  rmation may return in up to 48 hours, with only 30 
to 50% of presentations having positive blood cultures. Early treatment 
compliance has demonstrated a decrease in sepsis mortality. Thus, there 
remains a serious need for an early and accurate diagnostic test for severe 
sepsis. Insulin sensitivity (SI) is known to decrease with worsening condition 
and infl  ammatory response, and could thus be used to aid clinical treatment 
decisions. Some glucose control protocols are able to accurately identify SI in 
real time, without high rates of hypoglycemia [1]. This research explores the 
diagnostic test properties of a real-time test for severe sepsis.
Methods  A diagnostic biomarker for severe sepsis was developed from 
retrospective SI and concurrent temperature, heart rate, respiratory rate, 
blood pressure, and SIRS score from 36 adult patients with sepsis. Patients 
were identifi  ed as having severe sepsis based on a clinically validated sepsis 
score (ss). Kernel density estimates were used for the development of joint 
probability density profi  les for ss ≥2 and ss <2 data hours (213 and 5,858, 
respectively, of 6,071 total hours) and for classifi  cation. From the receiver 
operator characteristic (ROC) curve, the optimal probability cutoff   values 
for classifi  cation were determined, as well as AUC, positive and negative 
likelihood ratios (LHR), predictive values, and diagnostic odds ratios (DOR) 
for in-sample and out-of-sample estimates, respectively.
Results A biomarker including concurrent insulin sensitivity and clinical data 
for real-time diagnosis of severe sepsis (ss ≥2) achieves 69 to 94% sensitivity, 
75 to 94% specifi  city, 0.78 to 0.99 AUC, 3 to 17 LHR+, 0.06 to 0.4 LHR–, 9 to 
38% PPV, 99 to 100% NPV, and 7 to 260 DOR for optimal probability cutoff   
values of 0.32 and 0.27 for in-sample and out-of-sample data, respectively. 
The overall result lies between these minimum and maximum error bounds. 
See Figure 1.
Conclusions The clinical biomarker shows good to high accuracy and may 
provide useful information as an early real-time diagnostic test for severe 
sepsis.
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Introduction  Procalcitonin (PCT) is a highly specifi   c marker of severe 
bacterial infections and organ failure due to sepsis. The aim of the present 
study was to determine the diagnostic value of serum PCT in ICU patients 
with bacteremia caused by either Gram-negative or Gram-positive bacteria.
Methods During this prospective study, PCT levels were measured in 163 
adult patients with proven systemic monobacterial infections. Bacteremia 
was defi  ned as the recovery of any bacterial species and for coagulase-
negative Staphylococci (CNS) the species that were included were those 
harboring the same antibiotic pattern grown from at least two consecutive 
samples. Blood for PCT levels and culture was drawn simultaneously at the 
onset of bacteremia. Eighty-eight episodes of bacteremia were caused by 
Gram-positive bacteria: Staphylococcus aureus 12, CNS 56, Enterococcus spp. 
13, Streptococcus pneumoniae 3, Clostridium perfrigens 1 and Corynebacterium 
acnes 3. The remaining 75 episodes of bacteremia were caused by Gram-
negative bacteria: Escherichia coli 16, Klebsiella pneumoniae 19, Pseudomonas 
aeruginosa 15, Acinetobacter baumannii 24, and Serratia marscensens 1. Serum 
PCT was estimated with an assay based on immunochemiluminescence 
(BRAHMS Diagnostica, Berlin, Germany).
Figure 1 (abstract P13).
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caused by Gram-negative bacteria (75/75) were >2 ng/ml. In more details in 
41 patients with Gram-negative bacteremia (54.7%) the PCT levels were 2 to 
10 ng/ml and in 34 patients (45.3%) were >10 ng/ml while in patients with 
CNS bacteremia the PCT levels were >2 ng/ml only in 14% (6/56). In addition, 
in all patients with bacteremia caused by S. aureus the PCT levels were >2 ng/
ml and by Streptococcus spp., C. perfrigens, and C. acnes the PCT levels were 2 
to 10 ng/ml.
Conclusions PCT levels were markedly higher in patients with bacteremia 
associated with Gram-negative bacteria than in those with Gram-positive 
bacteremia, especially caused by CNS. Future research is needed to confi  rm 
our results.
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Administration of bacterial cell wall component lipopolysaccharide (LPS) 
stimulates the immune and endocrine systems, inducing acute phase of 
sickness and stress responses. Neonatal LPS exposure has been shown 
to alter many aspects of adult physiology, including neuroendocrine, 
neurochemical, and febrile responses. The aim of this study was to evaluate 
the eff  ects of neonatal immune challenge on adults during septic shock-
like condition assessing mean arterial pressure and heart rate, plasma 
vasopressin (AVP) concentration, body temperature (Tb), and macrophage 
nitric oxide (NO) synthesis. Male Wistar rats were exposed to LPS (100 μg/
kg i.p.; nLPS) or saline administration (nSal) 14 days after birth (P14). On day 
50 after birth, endotoxemic shock was induced by intraperitoneal injection 
of 10 mg/kg LPS, on rats previously implanted with polyethylene catheters 
in the femoral artery and loggers for Tb measurements. A diff  erent set 
of animals was used to assess the eff  ect of neonatal LPS exposure on NO 
synthesis by peritoneal macrophage in vitro, with (1 μg/ml) or without LPS, 
added to the culture. In nSal rats, LPS injection induced a transitory increase 
in AVP plasma concentration, a decrease in mean arterial pressure with 
a concomitant increase in heart rate, which were statistically signifi  cant 
from 1 hour (P <0.01) up to 6 hours (P <0.001) after treatment. LPS-induced 
hypothermia (P <0.05) was observed for 2 hours after LPS administration, and 
was followed by an increased Tb (P <0.01). We also observed a signifi  cant 
increase in nitrate plasma concentration as well as in macrophage culture 
medium after LPS stimulation. In nLPS rats we observed an attenuation 
to the development of hypotension, no signifi  cant change in heart rate 
(P <0.05), an increased hypothermia, and a decreased febrile response, and 
further increased (P <0.01) AVP plasma levels were observed, in response to 
LPS administration. Interestingly, nitrite released in the culture medium was 
attenuated in nLPS animals. Neonatal exposure to LPS induces attenuation 
in hypotension during septic shock-like conditions and this response may 
involve an increased AVP release.
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Immune challenges during the neonatal period may permanently program 
immune responses later in life, including endotoxin fever. We tested the 
hypo  thesis that neonatal endotoxin exposure aff  ects stress fever in adult 
rats. In control rats (treated with saline as neonates; nSal) body temperature 
peaked ~1.5°C during open-fi  eld stress, whereas in rats exposed to endotoxin 
(lipopolysaccharide, LPS) as neonates (nLPS) stress fever was signifi  cantly 
attenuated. Following stress, plasma corticosterone levels signifi  cantly 
increased from 74.29 ± 7.05 ng/ml to 226.29 ± 9.87 ng/ml in nSal rats, and 
from 83.43 ± 10.31 ng/ml to 324.7 ± 36.87 ng/ml in nLPS rats. Animals treated 
with LPS as neonates and adrenalectomized 1 week before experimentation 
no longer displayed the attenuated febrile response to stress. This attenuated 
stress fever caused by an increased corticosterone secretion is likely to be 
linked to an inhibitory eff  ect of glucocorticoids on cyclooxygenase activity/
PGE2 production in the preoptic/anteroventral third ventricular region 
(AV3V) since stress failed to cause a signifi  cant increase in PGE2 in nLPS 
rats, and this eff  ect was reverted by adrenalectomy. Altogether, the present 
results indicate that endogenous glucocorticoids are key modulators of the 
attenuated stress fever in adults rats treated with LPS as neonates, and they 
act downregulating PGE2 production. Moreover, our fi  ndings also support 
the notion that neonatal immune stimulus aff  ects programming of stress 
responses during adulthood, despite the fact that infl  ammation and stress 
are two distinct processes mediated largely by diff  erent neurobiological 
mechanisms.
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Introduction Alcohol consumption is a signifi  cant risk factor for mortality in 
patients with sepsis. Alcohol is the most widely abused substance worldwide 
and numerous studies have revealed that it has widespread eff  ects on the 
immune system and leaves abusers at increased risk of a variety of infections. 
An increased predisposition to infection among patients with alcohol use 
problems may also mediate an association with sepsis.
Objective The present study was carried out to investigate the mechanisms 
by which acute ethanol exposure alters the course of sepsis and the eff  ect of 
TLR4 signaling.
Methods Two diff  erent strains of mice, C3H/HeJ (TLR4-mutants) and C3H/
HeOuJ (wildtype), were treated with a dosage of 6 g/kg ethanol, which yields 
a blood-ethanol concentration of ~0.4%, similar to the blood-ethanol levels 
that occur in ethanol-dependent humans. Viable, indigenous Escherichia coli, 
log-phase, grown in LB broth was administered intraperitoneally. The dosage 
of E. coli was 2 × 108 per mouse, which serves as a model for loss of intestinal 
integrity and release of bacteria in large numbers. Blood samples were 
obtained retro-orbitally while the animal was under halothane anesthesia. 
After euthanasia, peritoneal lavage was performed and samples of this fl  uid 
were used to quantify bacteria by making serial dilutions in LB agar, and for 
cell-counting, for cytospin and cytokine and chemokine study. Spleen was 
also harvested from all the mice for carrying out bacterial quantifi  cation, RNA 
analysis, and fl  ow-cytometry analysis.
Results Ethanol administration decreases resistance to E. coli and causes a 
decrease in the ability to clear bacteria both from the peritoneal cavity as well 
as the spleen. At early time points, ethanol also suppresses the production 
of proinfl  ammatory cytokines (for example, IL-1, IL-17, IFNγ, TNFα, and so 
forth) and chemokines (for example, Eotaxin, RANTES, MIP-1, MIG, LIX, and 
so forth). Most (80 to 90%) of the cells in the peritoneal cavity were found to 
be macrophages (full of bacteria) and hardly any neutrophils could be found. 
See Figure 1.
Conclusions  Ethanol decreases clearance of bacteria in the peritoneal 
cavity and increases mortality. Ethanol also decreases production of most 
proinfl  ammatory cytokines and chemokines. A large number of macrophages 
in the peritoneal fl  uid indicates decreased attraction of neutrophils to the 
Figure 1 (abstract P17). Survival of TLR4 mutant (HeJ) versus wildtype mice.
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neutrophils in the peritoneal cavity, and, hence, increased mortality. TLR4 is 
dispensable for survival in E. coli sepsis but it also contributes to lethality in 
wildtype mice. Although TLRs have been implicated as an important element 
of host defense against infections, evidence indicates that these receptors 
may also play a crucial role in the pathophysiology of sepsis.
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Introduction Sepsis hyperglycemia is poorly understood. It is not known 
whether there is a role in sepsis hyperglycemia for glucagon-like peptide-1 
(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), crucial 
for normal glucose metabolism. We developed an in vitro model of sepsis 
employing monocytes (crucial cells in mediating sepsis) and hepatocytes 
(crucial cells in carbohydrate homeostasis) to clarify the role of the incretin 
system in sepsis.
Objective To establish an in vitro model of sepsis employing monocytic (U937) 
and hepatocytic (HUH7) cell lines by co-incubation with lipopolysaccharide 
(LPS) and to determine whether receptor expression for GIP, GLP-1, and 
insulin (INS) was altered.
Methods U937 (monocyte cell line) and HUH7 (hepatocyte cell line) cells 
were cultured with diff  erent concentrations of LPS for 24 hours. Real-time 
RT-PCR quantitation of gene expression was used to compare the rates for 
relative expression.
Results U937 and HUH7 cells expressed mRNA GIPR (including GIPR protein 
expression in HUH7 cells), and INSR, but only HUH7 expressed GLP-1R. There 
was an inverse relationship between the LPS dose and mRNA expression 
for GIPR (P <0.05). For example at 5 μg/ml LPS, the expression of GIPR was 
reduced to 86% and INSR 72% of control in U937: while in HUH7 cells at 
1 μg/ml LPS, the GIPR expression was decreased to 63%, GLP-1R 95% and 
INSR 89% compared with control (P <0.001). A direct signifi  cant relationship 
between LPS and infl  ammatory cytokines IL-1 (P <0.05) and IL-6 (P <0.05) in 
both cell lines validated our model.
Conclusions We not only show for the fi  rst time GIPR mRNA expression on 
U937 cells and expression of GIPR and GLP-1R on hepatocyte cell line, but 
also their downregulation with LPS. The LPS-mediated alteration in incretin 
receptor expression on these cell lines may be relevant to changes in 
cytokine secretion and carbohydrate metabolism in sepsis.
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Introduction Soluble CD14 subtype (sCD14-ST) is a fragment of CD14 and 
is markedly increased in sepsis patients. We developed a new immunoassay 
to detect sCD14-ST and evaluated the effi   cacy of this marker for diagnosis 
of sepsis. For developing the strategies of sCD14-ST as a sepsis diagnostic 
marker, the induction mechanism must be known.
Methods To determine the kinetics of sCD14-ST in the rabbit endotoxin 
shock model and the cecal ligation and puncture (CLP) model, we prepared 
the rabbit sCD14-ST immunoassay. Induction by infl  ammatory inducers and 
inhibition of sCD14-ST production were assessed using rabbit abdominal 
cavity granulocytes. Fragmentation of CD14 by N-aspartic protease was 
analyzed by western blot analysis and immunoassay.
Results sCD14-ST was induced in the CLP model. However, sCD14-ST was 
not induced in the endotoxin shock model. These results suggested that 
sCD14-ST was not induced after stimulation by physiologic activating 
agent but induced by bacterial infection. sCD14-ST was not induced after 
stimulation of rabbit granulocytes by LPS, IFNγ, FMLP, and PMA. In contrast, it 
was induced by adding Escherichia coli, indicating that sCD14-ST is produced 
by phagocytosis rather than infl   ammation. The phagocytosis inhibitors 
cytochalasin D and wortomanin inhibited the production of sCD14-ST in 
vitro. Additionally, N-asparagin protease inhibitor inhibited the production 
of sCD14-ST from granulocytes. Additionally sCD14-ST was detected from 
recombinant CD14 digested supernatant by cathepsin D enzyme.
Conclusions These data suggested that induction mechanism of sCD14-ST is 
dependent on the phagocytosis and cathepsin D is one of the enzymes for 
fragmentation of CD14. This mechanism is strong evidence for explanation 
of the production of sCD14-ST in sepsis patients.
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Introduction There is evidence that early delivery of antibiotics following 
the recognition of severe sepsis leads to decreased morbidity and indeed 
mortality. It is estimated that 36,800 people die annually in the UK as a result 
of severe sepsis, claiming more lives than bowel and breast cancer combined 
[1]. Patients admitted to ICUs with severe sepsis have a 39.8% risk of death 
[2], and for each hour delay in antibiotic administration, a 7.6% increase 
in mortality [3]. The Surviving Sepsis Campaign 2008 recommends that 
appropriate antimicrobial therapy be administered within 1 hour following 
recognition of severe sepsis [4].
Methods We conducted a prospective audit of consecutive patients with 
severe sepsis admitted to an ITU between February and June 2010. The 
patients were identifi  ed as those who fulfi  lled two or more components 
of the systemic infl  ammatory response syndrome (SIRS) criteria, and had 
evidence of organ dysfunction requiring critical care. Compliance to the 
Surviving Sepsis Campaign’s antibiotic care bundle was audited. The 
relationship between time of antibiotic administration and mortality was 
also determined.
Results During the study period, 33 patients out of 187 admissions met the 
inclusion criteria. The population demographics are illustrated in Table 1. 
The mean time from fulfi  lling SIRS criteria to delivery of antibiotics was 
4.32 hours. Only eight (25%) of the patients received antibiotics within the 
Table 1 (abstract P20). Demographic characteristics of 33 patients with 
septic shock treated in an ICU
Variable Number  (%)
Mean age (years)  62.1
Male gender  20 (65)
Deaths 11  (330
Source of sepsis 
 Chest  21  (75)
  Urinary tract  5 (15)
 Intraabdominal  3  (9)
  Soft tissue  2 (6)
 Other  2  (6)
SIRS criteria 
  Temperature >38 or <36°C  16 (49)
  HR >90 bpm  33 (100)
  RR >20/min or PCO2 <4.3 kPa  26 (78)
  WBC >12 or <4 c/mm3  24 (72)
  >2 SIRS criteria  33 (100)
  Systolic BM <90 mmHg  17 (51)
  Lactate >4 mol/l  5 (15) (unrecorded 36%)
  Organ dysfunction  28 (64)
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received antibiotics after 4 hours had a lower mortality rate than the group 
that received antibiotics after 12 hours (67% vs. 80%). See Figure 1.
Conclusions Our results support published evidence that a delay in antibiotic 
delivery greater than 1 hour is associated with increased mortality in patients 
treated in the ITU. As a result of this study we have developed a standardized 
sepsis protocol to integrate into the AE triage pro forma, as well as a pathway 
to help instigate treatment earlier to those patients identifi  ed as septic on 
the wards. Recruitment period has not concluded. More data analysis will be 
presented later.
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Introduction Acute lung injury (ALI) caused by smoke inhalation with or 
without bacterial pneumonia remains a signifi  cant cause of morbidity and 
mortality among burn patients. Bacterial pneumonia in an ALI patient is 
particularly worrisome because it often leads to sepsis. Although much of 
the literature surrounding ALI and pneumonia-induced sepsis has rightfully 
focused on pulmonary and endothelial changes, a major consequence of ALI 
and an area of continued research and drug development is coagulopathy. 
The objective, therefore, of our study was to determine whether coagulopathy 
diff  ers between types of ALI and whether the dysregulation can be estimated 
using a disease progression model.
Methods  Nineteen sheep with acute lung injury were incorporated into 
this pneumonia-sepsis model. Pneumonia was induced by inoculating the 
airway with ~2.5 × 1011 colony-forming units (CFUs) methicillin-resistant 
Staphylococcus aureus (MRSA), while smoke injury was created through 
inhalation of cotton smoke. The injury groups studied were as follows; MRSA 
and smoke inhalation (M+S), MRSA untreated (M), MRSA treated (M+T), 
and smoke inhalation only (S). Data were modeled over 24 hours. First, all 
the sheep were modeled together to determine a rank-order of the injury 
groups. After rank-ordering the groups, the groups became model inputs 
and in conjunction with other clinical and laboratory variables were used to 
estimate the output parameter, prothrombin time (PT). In order to minimize 
overparameterization of a small patient population, the model was allowed 
to estimate PT using only two parameters.
Results The number of sheep in each group was as follows; seven M+S, 
three M, three M+T, and six S. The rank-order of injury from least to greatest 
severity was M+T, S, M, M+S. The two highest-ranking parameters in 
estimating PT were calcium and injury. When using calcium and injury alone, 
the model estimate agreement with measured PT was r2 = 0.70 and r2 = 0.36, 
respectively. Allowing the model to combine the inputs did not improve the 
model estimate (r2 = 0.70) compared with when calcium was used alone.
Conclusions  The progression model allowed all individual sheep to be 
characterized as to the severity of resulting coagulopathy and identifi  ed 
some important co-factors. Acute lung injury can lead to systemic 
coagulopathy even without MRSA infection, but the extent and severity is 
greater with infection.
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Introduction  Septic syndromes are a culmination of multiple partially 
under  stood dynamic processes. However, it is now established that, after 
a transient exacerbated proinfl   ammatory response, a counter-regulatory 
phase develops, rapidly inducing immune alterations that are thought 
to play a major role in patients’ mortality and susceptibility to nosocomial 
infections. Programmed Death-1 (PD-1) receptor and its ligands PD-L1 
and PD-L2 constitute a newly described pathway that negatively controls 
immune responses. Recently, improved bacterial clearance and decreased 
mortality were observed in PD-1 knockout mice [1]. The objective of the 
present study was to investigate PD-1-related molecule expressions in septic 
shock patients.
Methods  PD-1-related molecule expressions were measured by fl  ow 
cytometry on circulating leukocytes from 64 septic shock patients and 49 
healthy individuals. Severity scores (SAPS II, SOFA), clinical events (28-day 
mortality, occurrence of nosocomial infections) and the usual biomarkers 
of sepsis-induced immunosuppression (monocyte HLA-DR expression, 
lymphocyte phenotyping including Treg, plasmatic IL-10 concentration) 
were assessed. Ex vivo functional assays such as lymphocyte proliferation ([3H] 
thymidine incorporation) in response to phytohemagglutinin, and cytokine 
release (TNFα and IL-10 assessed by Bio-Plex technique) after overnight LPS 
incubation, were performed in the presence of blocking antibodies against 
PD-1-related molecules.
Results Patients presented with typical features of sepsis-induced immuno-
suppression (decreased mHLA-DR expression, increased Treg percentage, 
decreased LPS-induced TNFα release). At days 1 to 2 and days 3 to 5 after 
the onset of shock, patients displayed increased PD-1 and PD-L1 expressions 
on CD4+ T lymphocytes and enhanced PD-1, PD-L1 and PD-L2 expressions 
on monocytes. See Figure 1 overleaf. Nonsurvivors presented with 
increased mono  cyte PD-L1 expression while enhanced monocyte PD-1 
or PD-L2 expressions were associated with the occurrence of secondary 
nosocomial infections. In addition, decreased mitogen-induced lymphocyte 
proliferation was negatively correlated with increased lymphocyte PD-1 and 
PD-L1 expressions whereas monocyte PD-1-related molecule expressions 
were highly correlated with increased circulating IL-10 concentration. No 
benefi  cial eff  ects of anti-PD-1-related molecule antibodies were observed.
Conclusions We describe here for the fi  rst time the overexpression of PD-
1-related molecules on circulating leukocytes in septic shock patients. 
Importantly, these increased expressions were signifi  cantly associated with 
the occurrence of immune dysfunctions, secondary nosocomial infection, 
and death after septic shock. Taken together, our results suggest that PD-1-
related molecules may constitute an additional regulatory system involved 
Figure 1 (abstract P20). Time from diagnosis of severe sepsis to antibiotics. 
Line represents percentage of mortality, and bars represent number of cases 
in each outcome category for time periods.
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perspectives for the treatment of this hitherto deadly disease.
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Introduction The severe form of sepsis is associated with multiple organ 
dysfunction syndrome (MODS), but the precise mechanisms by which MODS 
develops remain unclear. Neutrophils are essential cellular components 
of the innate immune system that have conserved roles in bacterial 
containment. Paradoxically, however, neutrophils also mediate tissue injury 
in varied human diseases, including sepsis.
Objective In the present study, we investigated the role of chemokine 
receptor CCR2 in driving neutrophil infi  ltration and eliciting tissue damage 
in remote organs during sepsis.
Methods and results We demonstrated that neutrophils, which are normally 
unresponsive to CCR2 chemokines, acquired substantial chemotaxis to 
CCL2 and CCL7 when exposed to LTA (4.33-fold and 3.02-fold increase, 
respectively) or LPS (4.67-fold and 3.29-fold increase, respectively). Moreover, 
consistent with the functional response, we found that TLR2 and TLR4 
signaling through the MyD88/NF-κB pathway mediates the upregulation 
of CCR2 and chemotactic responsiveness to CCR2 ligands on neutrophils. 
In vivo, intravenous injection of TLR ligands or induction of cecal ligation 
and puncture (CLP)-induced sepsis triggered chemotaxis of circulating 
neutrophils to CCR2 chemokines, which was completely abolished in MyD88-
defi  cient mice. Notably, CCR2-defi  cient (CCR2–/–) or WT mice treated with 
CCR2 antagonist (RS504393, 2 mg/kg) showed a signifi  cant increased survival 
rate after CLP when compared with WT mice. Defi  ciency or pharmacology 
blockade of CCR2 attenuated neutrophil infi  ltration (by myeloperoxidase 
activity) into the lungs, heart, and kidneys, which was associated with 
reduction of serum biochemical markers of organ injury/dysfunction. 
Importantly, neutrophils from septic patients (n = 19, prospected in survivors 
(S) and nonsurvivors (NS)) showed an increase of median of fl  uorescence 
intensity (MFI) of CCR2 by fl  ow cytometry (S = 5.76 ± 2.30 vs. NS = 9.12 ± 1.72, 
MFI), which was related to the chemotactic response to CCL2 (S = 6.35 ± 0.68 
vs. NS = 10.56 ± 2.38, neutrophils/fi  eld). Furthermore, there was a positive 
correlation between SOFA scores with the neutrophil response to CCL2 
(r2 = 0.62, P <0.01).
Figure 1 (abstract P22). PD-1, PD-L1 and PD-L2 measurements on circulating monocytes and CD4+ lymphocytes in septic shock patients and healthy volunteers. 
PD-1-related molecule expressions were measured on (a) circulating monocytes and (b) CD4+ lymphocytes in whole blood from healthy volunteers (n =40) and 
septic shock patients at D1 to D2 (n = 37) and at D3 to D5 (n =56) after the onset of shock. Results presented as percentages of positive cells among total population 
of monocytes or CD4+ lymphocytes and as boxplots and individual values. *P <0.020, **P ≤0.002 (Mann–Whitney test). P <0.025 was considered statistically signifi  cant 
(with correction by the number of tests).
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that drives the inappropriate infi  ltration of neutrophils into remote organs 
during sepsis. Therefore, CCR2 blockade could be an adjuvant therapeutic 
strategy for treatment of sepsis-induced MODS.
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Introduction The prognostic capability of TNFα and IL-6 is limited in septic 
shock. Previous studies were performed prior to publication of current 
therapeutic guidelines recommending aggressive early resuscitation. The 
objective of the present study was to evaluate the impact of early fl  uid 
resuscitation on serial TNFα and IL-6 levels and its association with mortality 
in severe sepsis.
Methods  This is a substudy of a previously completed prospective, 
observational multicenter investigation of patients with severe sepsis. 
Inclusion criteria were age >17, infection with ≥2 SIRS, hypotension despite 
fl  uid challenge, treatment with a standardized quantitative resuscitation 
protocol, and identifi  cation within 3 hours of treatment initiation. Blood 
samples were obtained at enrollment, 6 hours, and 24 hours. Therapeutic 
amounts of intravenous crystalloid fl  uid was defi  ned by ≥5 l and <5 l over 24 
hours (initial 2 l fl  uid challenge over 4 hours followed by 150 ml/hour for 20 
hours). Data analysis compared absolute levels of TNFα and IL-6 at each time 
point between survivors and nonsurvivors. The magnitude and direction of 
serial cytokine levels was quantifi  ed by the percentage diff  erence of each 
marker for each patient between 0 and 6 hours and 0 and 24 hours. Statistical 
analysis was performed using the Wilcoxon-rank-sum test or the Student t 
test.
Results Forty patients were enrolled; 11 died. Vasopressors were required 
in 60% of all patients. Absolute values of IL-6 (pg/ml) were higher in 
nonsurvivors than survivors at enrollment (5,479 vs. 710); 6 hours (4,180 vs. 
405), and 24 hours (5,710 vs. 377) (P <0.05). There was no diff  erence in TNFα 
values between the two groups (P = NS at 0, 6, 24 hours). Nonsurvivors had 
a larger percentage (diff  erence) in both TNFα and IL-6 than survivors at 24 
hours. See Figure 1. Treatment with ≥5 l intravenous fl  uid over 24 hours was 
associated with a 32% decline in IL-6 compared with a 64% increase in IL-6 
with <5 l fl  uid therapy. See Figure 2.
Conclusions In the context of a quantitative protocol for the treatment of 
severe sepsis, high-volume fl  uid resuscitation is associated with a decline 
in the percentage diff  erence of IL-6. Trends in the percentage diff  erence 
of both TNFα and IL-6 diff  erentiate survivors from nonsurvivors. Further 
investigation is needed into the impact fl  uid resuscitation has on decreasing 
the infl  ammatory insult and the use of serial cytokine measurements as a 
measure of therapeutic eff  ectiveness.
Acknowledgements Conducted within the Emergency Medicine Shock 
Research Network (EMShockNet). RA has no fi  nancial disclosures relevant to 
this study but has received research funding from Hutchinson Technologies. 
The present study was supported in part by a grant from the Shock Society/
Novo Nordisk research grant for Hemorrhagic Shock and Hemostasis to ST. 
AJ’s eff  ort is supported by a grant from the National Institutes of Health/
National Institutes of General Medical Sciences K23GM076652. NS is 
supported in part by grants from the National Institutes of Health L091757 
and GM076659.
P25
Severity of illness scoring systems in community-acquired Legionella 
pneumonia
Ø Simonsen, J Ringstad
Østfold Hospital Trust, Medical Department, Fredrikstad, Norway
Critical Care 2010, 14(Suppl 2):P25 (doi: 10.1186/cc9128)
Introduction Prognostic and severity-of-illness scoring systems are valuable 
tools for predicting mortality and choosing the site of care for patients with 
community-acquired pneumonia (CAP) [1]. Legionnaires’ disease (LD) is a 
pneumonia caused by Legionella spp. and carries a higher mortality rate (5 to 
30%) than CAP of most other etiologies. The aim of our study was to evaluate 
fi  ve scoring systems commonly used in CAP for predicting mortality in 
patients with Legionella pneumophila serogroup 1 infection admitted during 
a large LD outbreak [2,3].
Methods  Patients with microbiologically verifi  ed LD (n  =  103) and CAP 
patients with epidemiological association to the outbreak with no other 
bacteriological etiology identifi  ed (n = 32) were included. A clinical protocol 
was initiated during an early phase of the outbreak, and clinical and 
biochemical data were collected from patients on admission to the regional 
hospital. The fi  ve evaluated scoring systems were: pneumonia severity index 
(PSI), CURB-65 (confusion, uremia, respiratory rate ≥30, low blood pressure, 
age ≥65) and CRB-65 score, the modifi  ed American Thoracic Society (ATS) 
score, and the IDSA/ATS guidelines. The endpoint was defi  ned as 28-day 
mortality.
Figure 1 (abstract P24). %Δ IL-6 and TNF.
Figure 2 (abstract P24). %Δ at 24 hours.
Table 1 (abstract P25). Sensitivity, specifi  city and predictive values for 
mortality prediction of fi  ve severity-of-illness scoring systems in 132 
outbreak patients with confi  rmed and presumptive Legionnaires’ disease
 Sensitivity  Specifi   city   
 ( n = 16) (%)  (n = 119) (%)  PPV (%)  NPV (%)
PSI class IV and V  94  44  19  98
CURB-65  score  ≥2  88 47 19 97
CRB-65  score  ≥2  81 58 21 96
Modifi   ed  ATS  31 91 31 91
IDSA/ATS  63 77 26 94
PPV, positive predictive value; NPV, negative predictive value.
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admitted to the ICU. The discriminatory power was highest for PSI, CURB-
65 and CRB-65 with area under the receiver operator characteristic curve 
(AUC) of 0.79, 0.78, and 0.75, respectively. The AUC of the modifi  ed ATS score 
and IDSA/ATS guidelines were 0.61 and 0.69, respectively. Table 1 shows 
that a PSI class IV or V, and a CURB-65 and CRB-65 score ≥2 yielded the 
highest sensitivity for prediction of mortality, but the specifi  city and positive 
predictive value was low.
Conclusions The PSI, the CURB-65 and CRB-65 scores proved sensitive in 
predicting mortality in patients with Legionella pneumonia admitted during 
an LD outbreak, but the low specifi  cities and positive predictive values 
necessitate thorough clinical judgment in patients with a high severity 
score. The modifi  ed ATS score and IDSA/ATS guidelines, which are decision 
recommendations for ICU admission, were not sensitive in predicting 
mortality from LD in this study.
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Introduction  Sepsis accounts for a huge number of deaths in ICUs 
worldwide. Sepsis describes a complex clinical syndrome that results from an 
infection, setting off   a cascade of systemic infl  ammatory responses that can 
lead to multiple organ failure and death. Leite and colleagues have shown 
that mice fed for 6 weeks with an olive oil diet were resistant to endotoxic 
shock, with 60% survival at 168 hours [1]. Olive oil is composed of diff  erent 
polyunsaturated fatty acids such as omega 3 and 6, but the monounsaturated 
fatty acid omega 9, also known as oleic acid (OA), that is the main component 
of olive oil, is highly consumed in the Mediterranean diet.
Objective We aim to investigate the role of OA in an experimental model of 
sepsis.
Methods Swiss mice were given daily doses (orally) of OA, at 282 μg/animal, 
for 15 days. Control animals received saline. On the 16th day, polymicrobial 
sepsis was induced by cecal ligation and puncture (CLP). Immediately 
after the procedure, all mice received volemic reposition and after 6 hours 
animals were given imipenem. Twenty-four hours after surgery, mice were 
euthanized and the peritoneal cavity was rinsed with sterile saline. Total 
leukocyte counts were performed in a Neubauer chamber and diff  erential 
leukocyte were stained with May–Grunwald Giemsa. The supernatant 
and plasma were collected for cytokine quantifi  cation. In another set of 
experiments, the survival rate was determined daily for 7 days in separate 
groups of 10 animals for each condition.
Results Mice fed with OA were resistant to sepsis, with a 64% survival rate at 
168 hours compared with saline-treated mice (33%). OA supplementation in 
CLP-subject animals led to a signifi  cant decrease in the total leukocyte counts 
(10.69 × 106 ± 1.71), mainly neutrophils, compared with mice that received 
saline (20.30 × 106 ± 2.69). However, in mice that consumed OA the levels of 
TNFα, IL-10 and IL-6 were not signifi  cantly diff  erent from mice fed with saline 
submitted to CLP. Interestingly, preliminary data showed that mice fed with 
OA had a lower level of bacteria in the peritoneal lavage leukocyte compared 
with mice submitted to CLP. See Figure 1.
Conclusions Our data suggest that treatment with OA reduces mortality in an 
experimental model of sepsis and attenuates infl  ammation. One mechanism 
involved may be due to an increased bacterial clearance in mice fed with OA. 
More data are required to clarify this mechanism of increased survival.
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Introduction Sepsis is a leading cause of death in critically ill patients and 
is characterized by a marked increase of the host proinfl  ammatory cytokine 
release that is precipitated by infectious agents. The sepsis response to therapy 
has not appreciably improved. The procalcitonin (PCT) concentration is 
increased in the serum samples of septic patients and correlates with severity 
of the illness. LPS is a pivotal bacterial product involved in pathogenesis of 
sepsis and septic shock. Preventing the beginning of infl  ammatory systemic 
cascade by means of LPS modulating agents might have a valuable eff  ect 
in the control of such deadly illness. The aim of the present study was to 
Figure 1 (abstract P26). Bacterial count in the peritoneal lavage leukocyte is 
lower in oleic acid-treated mice submitted to CLP.
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of cytokines from human PBMC.
Methods  S. typhimurium LPS was preincubated with human PCT and 
then was added to freshly isolated human PBMC cultures in RPMI 1640. In 
such cultures the fi  nal concentrations of LPS and PCT were 10 ng/ml and 
either 5,000 or 500 ng/ml respectively. A panel of cytokines was evaluated 
on culture supernatants by Biochip microarray (Randox) and PCT was 
tested by ELFA. Data analysis was carried out by a nonparametric method 
(Mann–Whitney U test, Graph Pad Prism version 4.03) to establish statistical 
diff  erences between groups.
Results Both of the PCT concentrations used signifi  cantly (P <0.05 vs. LPS-
stimulated PCT-free controls) reduced TNFα (after 4-hour incubation with 
LPS) and MCP-1 (24 hours following LPS challenge). The lower concentration 
of PCT was also able to signifi  cantly (P<0.05 vs. LPS-stimulated PCT-free 
controls) decrease the TNFα and IL-2 levels in the 24-hour samples.
Conclusions PCT, besides the well-known role as marker of sepsis, could be 
a potentially useful molecule to control systemic infl  ammatory mediators in 
both sepsis and septic shock.
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Introduction Sepsis is a major cause of morbidity and mortality in intensive 
care clinics and the incidence is continuously increasing. Estimated mortality 
rates are over 30% for patients with severe sepsis and over 50% for patients 
with septic shock. Endotoxins, or lipopolysaccharides (LPSs), are a major 
component of the cell membrane of Gram-negative bacteria. LPS is well 
known to induce a strong response from the immune system leading to 
release of infl  ammatory mediators and occasionally sepsis, or even septic 
shock. The aim of our study is to investigate the clinical eff  ects of adding 
treatment with the Alteco® LPS Adsorber (Alteco Medical AB, Lund, Sweden) 
to standard therapy for patients with septic shock.
Methods Our study included 12 patients with septic shock and endotoxemia 
randomized 1:1 to standard therapy plus LPS adsorption (adsorber group 
(AdG), n = 6) or standard therapy alone (reference group (RefG), n = 6). 
Randomization of patients will be performed using sealed envelopes. 
This included fi  ve women and seven men; mean age 47.3 ± 24.8 years. All 
patients needed inotropic support and mechanical lung ventilation. The 
mean APACHE II score at start of treatment was 26.6 ± 2.3. Both groups in the 
study received standard therapy (Surviving Sepsis Campaign International 
Guidelines 2008) for patients in septic shock. For patients in the study group, 
treatment with the Alteco® LPS Adsorber was added to standard therapy. 
The adsorber treatment was initiated immediately after inclusion in the 
study; that is, as soon as possible after onset of septic shock. The duration of 
Alteco® LPS Adsorber treatment was 120 minutes repeated twice within 24 
hours. Hemofi  ltration/hemoperfusion in the study group was not carried out 
during the perfusion. Samples for endotoxin and PCT analysis shall be taken 
from the arterial line. Hemodynamic parameters are registered according to 
routines at the clinic (PICCO technology).
Results Hemodynamic data, laboratory results, and blood gas analysis are 
summarized in Table 1. LPS was signifi  cantly lower in all patients in the study 
group after treatment. No complications related to the use of the Alteco® LPS 
Adsorber were seen and all patients in this group were discharged from the 
ICU after 45 to 68 days, respectively.
Conclusions We have received a statistically signifi  cant improvement in 
hemodynamics, oxygenation, and reduced markers of endotoxemia in group 
therapy with Alteco® LPS Adsorber compared with traditional therapy. These 
eff  ects were attributed with the removal of endotoxin from the systemic 
circulation. Only in one case using hemofi  ltration for acute renal failure in 
the study group (in the reference group in all patients), 28-day mortality was 
16.7% and 66.7% respectively. Negative eff  ects were negligible.
P29
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Table 1 (abstract P28). Results from analyses of samples
  Stage
 I  II  III  IV
Parameter  RefG AdG RefG Adg REfG Adg RefG AdG
LPS (EU/ml)  1.4 ± 0.0  1.4 ± 0.0  1.4 ± 0.2  0.8 ± 0.2  1.4 ± 0.6  0.4 ± 0.3  1.4 ± 0.2  0.2 ± 0.0
PCT (ng/ml)  15.6 ± 2.8  16.0 ± 2.5  16.4 ± 2.2  11.6 ± 3.7  14.3 ± 2.8  4.2 ± 2.2  13.6 ± 3.8  1.4 ± 0.9
CI (l/min/m2)  2.7 ± 0.8  2.9 ± 0.7  2.9 ± 0.8  3.9 ± 0.9  3.1 ± 0.6  3.0 ± 0.7  2.9 ± 0.5  4.7 ± 1.9
MAP (mmHg)  60.6 ± 4.3  59.1 ± 5.8  66.9 ± 5.5  79.7 ± 4.6  69.4 ± 1.4  81.1 ± 2.9  69.1 ± 3.2  83.8 ± 5.7
Pa2 (mmHg)  88.2 ± 2.1  84.5 ± 12.1  89.9 ± 14.4  108.7 ± 16.1  88.3 ± 9.4  129.4 ± 12.2  91.7 ± 7.8  130.6 ± 9.2
FlO2 (%)  60.0 ± 0.0  50.0 ± 4.1  50.0 ± 0.0  40.1 ± 4.3  50.0 ± 0.0  37.4 ± 3.5  50.0 ± 0.0  35.0 ± 0.0
ELWl (ml/kg)  12.9 ± 3.3  13.2 ± 1.2  13.1 ± 2.2  9.2 ± 3.1  11.0 ± 2.7  7.1 ± 1.1  9.7 ± 2.1  4.3 ± 2.1
PAO2/FiO2  146.4 ± 12.1  168.4 ± 16.5  179.2 ± 10.1  270.1 ± 24.3  176.3 ± 9.5  345.0 ± 21.1  183.2 ± 12.1  373.5 ± 14.3
Dopamin (μg/kg/min)  12.0 ± 1.7  13.3 ± 3.9  14.2 ± 2.2  8.1 ± 2.1  13.5 ± 3.1  3.3 ± 1.4  11.7 ± 1.9  3.1 ± 0.3
SaO2 (%)  87.3 ± 2.2  86.7 ± 3.1  86.9 ± 1.9  94.9 ± 2.8  89.5 ± 3.5  98.2 ± 0.9  93.6 ± 5.4  98.5 ± 0.4
SVO2 venous (%)  79.8 ± 2.5  80.0 ± 1.5  82.2 ± 2.3  76.0 ± 3.4  85.3 ± 3.1  71.3 ± 2.4  79.8 ± 2.9  72.8 ± 3.7
Lactate (mol/l)  4.9 ± 2.1  4.8 ± 1.7  5.5 ± 1.3  3.2 ± 1.1  5.3 ± 1.3  2.4 ± 0.9  5.4 ± 0.9  1.7 ± 0.6
APTt (sec)  41.5 ± 5.9  42.1 ± 4.6  46.6 ± 7.7  58.4 ± 5.7  48.8 ± 12.1  66.3 ± 8.5  50.2 ± 11.8  62.3 ± 3.4
I, baseline, prior to fi  rst adsorber treatment; II, prior to second adsorber treatment/day after fi  rst treatment; III, 2 days after second adsorber treatment/3 days after fi  rst 
adsorber treatment.
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Introduction Implantable ventricular assist devices (VADs) are widely used 
in patients with end-stage heart failure as a bridge to heart transplantation 
(HTx) or as destination therapy (DT); however, their use is associated with 
increased postoperative infection-related morbidity and mortality. Rapid 
identifi  cation of responsible organisms is imperative for the initiation of 
appropriate treatment and for lowering mortality due to sepsis. Direct 
detection of pathogens in blood samples by nucleic acid amplifi  cation is 
a sensitive and fast alternative to blood cultures. The multiplex real-time 
PCR system SeptiFast® (Roche Diagnostics) allows for rapid detection and 
identifi  cation of the 25 most common pathogens (Gram-positive and Gram-
negative bacteria and fungi) in blood, in less than 6 hours. The aim of this 
study was to evaluate the usefulness of SeptiFast® in patients with implanted 
VADs.
Methods The study included 103 blood samples from 38 VAD patients 
analyzed over a period of 24 months (January 2008 to December 2009), 
using SeptiFast® in parallel with blood cultures. Blood samples were 
obtained only from patients suspected of harboring an infection, and in 
case of positive results follow-up samples were obtained on a weekly basis. 
PCR was performed according to manufacturers’ description (SeptiFast®) 
using MagnaLyser for extraction of DNA from 1.5 ml peripheral blood and 
LightCycler 2.0 (Roche Diagnostics) for amplifi  cation and detection.
Results SeptiFast® and blood cultures yielded concurrent negative results in 
76% of the samples and positive results in 7.3% of them. There was a 75% 
concordance in species identifi  cation. Diverging results were obtained in 
10.3% of the samples where SeptiFast® only was positive and in 6.4% of the 
samples where blood cultures only were positive. In cases with concurrent 
positivity, acceptance of the SeptiFast® results could have led to an earlier 
targeted treatment.
Conclusions The PCR-based SeptiFast® test in combination with traditional 
microbiological methods may facilitate fast and specifi  c antibiotic treatment 
and may contribute to reduction of sepsis progressing infections in VAD patients.
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Introduction Tissue metabolic alterations during critical sepsis have not 
been well characterized.
Objective To investigate the tissue metabolic alterations during sepsis.
Methods A microdialysis (MD) catheter was inserted into the subcutaneous 
adipose tissue of the upper thigh in 65 (39 men) septic critically ill patients 
upon sepsis onset. Dialysate samples were analyzed for glucose, lactate, 
pyruvate, and glycerol. The lactate/pyruvate (L/P) ratio was calculated. 
Sampling was performed six times per day for a maximum of 6 days. The daily 
mean values of MD measurements were calculated for each patient. Eleven 
(fi  ve men) critically ill nonseptic patients served as controls.
Results Septic patients were older (66 ± 17 vs. 45 ± 20 years, P <0.001), and 
had a higher APACHE II score (21 ± 5 vs. 14 ± 6, P <0.001) along with a higher 
SOFA score (8 ± 3 vs. 3 ± 3, P <0.001) compared with nonseptic patients. 
Septic patients had a high tissue glucose (>4.6 mmol/l), lactate (>2 mmol/l), 
pyruvate (>120 μmol/l), L/P ratio (>25), and glycerol (>200 μmol/l) during 
almost the entire observation period. Septic patients had higher tissue 
glucose (P = 0.02) and glycerol (P = 0.04) levels than nonseptic patients 
during the whole study period. They also tended to have higher lactate 
(P  =  0.14) concentrations. In contrast, the two groups had similar tissue 
pyruvate (P = 0.35) and L/P ratios (P = 0.80).
Conclusions Critical sepsis is characterized by an excessive release of 
extracellular glucose, lactate, and glycerol, with the latter refl  ecting probably 
increased lipolysis. These mirror the well-known sepsis-related blood 
metabolic alterations. Thus, chemical monitoring with subcutaneous MD is 
accurate in severely ill septic patients.
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Introduction New endogenous antimicrobial peptides derived from 
the natural processing of chromogranin A (CgA) are co-secreted with 
catecholamines upon stimulation of chromaffi   n cells. Since PMNs play a 
central role in innate immunity, we examine responses by PMNs following 
stimulation by two antimicrobial CgA-derived peptides.
Methods PMNs were treated with diff   erent concentrations of CgA-
derived peptides in the presence of several drugs. Calcium mobilization 
was observed using fl   ow cytometry and calcium imaging experiments. 
Immunocytochemistry and confocal microscopy were performed to analyze 
the intracellular localization of the peptides. The calmodulin-binding 
and iPLA2-activating properties of the peptides were shown by surface 
plasmon resonance and iPLA2 activity assays. Finally, a proteomic analysis 
of the material released after PMN treatment with CgA-derived peptides was 
performed using HPLC and nano-LC MS–MS.
Results Using fl  ow cytometry we fi  rst observed that after 15 seconds, in 
the presence of extracellular calcium, chromofungin (CHR) or catestatin 
(CAT) induce a concentration-dependent transient increase of intracellular 
calcium. In contrast, in the absence of extracellular calcium the peptides 
are unable to induce calcium depletion from the stores after 10 minutes of 
exposure. Treatment with 2-aminoethoxydiphenyl borate, a store-operated 
channel blocker, inhibits completely the calcium entry, as shown by calcium 
imaging. We also showed that they activate iPLA2 as the two CaM-binding 
Figure 1 (abstract P32). CHR and CAT induce store-operated channel (SOC) 
activation.
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two CaM-binding domains reported for iPLA2. We fi  nally analyzed by HPLC 
and nano-LC MS–MS the material released by PMNs following stimulation by 
CHR and CAT. We characterized several factors important for infl  ammation 
and innate immunity. See Figure 1.
Conclusions For the fi  rst time, we demonstrate that CHR and CAT penetrate 
into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 
pathway [1]. Furthermore, new experiments show that CAT penetrates 
quickly into immune cells such as dendritic cells and macrophages. To 
conclude, this study highlights the role of two CgA-derived peptides in the 
active communication between neuroendocrine and immune systems.
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Introduction Septic shock is characterized by cardiac collapse and decreased 
peripheral resistance due to systemic resistance vessel dilatation, generally 
induced by large nitric oxide (NO). G-protein-coupled receptor (GPCR) kinases 
(GRKs), specifi   c kinases interacting with GPCR proteins, induce receptor 
phosphorylation and thereby signal desensitization in the continuing 
agonist presence. Then, an increased expression of GRKs could augment 
adrenergic receptor desensitization and in turn reduce cardiovascular 
responses. Thus, we hypothesized that the hyporesponsiveness observed in 
sepsis could result from signal adrenergic receptor desensitization mediated 
by GRK2 via a NO-dependent mechanism.
Methods  C57Bl/6 mice were submitted to cecal ligation and puncture 
(CLP) surgery and sham-operated animals as controls. The cardiovascular 
responsive  ness activity was evaluated in aorta rings or in cardiac ventricles. 
Aorta rings were contracted with phenylephrine (Phe; 1 μM), whereas 
ventricles were contracted with isoproterenol (Iso; 1 μM). The tissues 
responsiveness was evaluated 6, 12, and 24 hours after CLP surgery in the 
presence or absence of NO synthesis inhibitor (1400W; 100 μM; 30 min). 
GRK2 expression was analyzed on heart and aorta 6, 12, and 24 hours 
after CLP from sham, septic, and 1400W (1 mg/kg)-treated septic mice by 
immunofl  uorescence analysis. The procedures have been approved by the 
Animal Use Ethics Committees of UFSC (PP003).
Results The vascular responsiveness to vasoconstrictor Phe was signifi  cantly 
reduced in aorta rings from septic mice evaluated 6 hours (55%), 12 hours 
(57%), and 24 hours (78%) after CLP. However, the 1400W incubation 
prevented this vascular hyporesponsiveness 6 and 12 hours after CLP. The 
cardiac responsive  ness to Iso was signifi  cantly reduced in ventricles from 
septic mice evaluated 12 hours (73%) and 24 hours (88%) after CLP. Conversely, 
the 1400W incubation prevented this cardiac hyporesponsiveness 12 hours 
after CLP. Moreover, high expression of GRK was detected in aorta 6 hours 
(65%), 12 hours (70%), and 24 hours (88%), and heart of septic mice 12 hours 
(52%) and 24 hours (63%) after CLP. The 1400W treatment reduced the GRK 
high expression on the aorta (75%) and heart (79%) of septic mice.
Conclusions Our fi  ndings identify that NO seems to activate GRK, which 
may induce adrenergic receptors’ desensitization to agonists, contributing 
to severe cardiovascular hyporesponsiveness observed during septic shock. 
Therefore, the results suggest that GRK could be a new potential target to 
sepsis pharmacotherapy.
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The triggering receptor expressed on myeloid cells-1 (TREM-1) is a recently 
discovered cell surface molecule expressed on neutrophils, mature 
monocytes, and macrophages [1]. Activation of TREM-1 synergistically 
enhances proinfl   am  matory cytokine production induced by toll-like 
receptor (TLR) stimulation [2]. A soluble form of TREM-1 has shown promise 
as a sensitive and specifi  c biomarker for sepsis in humans [3-5]. Expression 
and function of TREM-1 in the dog has yet to be characterized. We 
hypothesize that the expression of canine TREM-1 will be upregulated after 
stimulation with TLR agonists. We assessed TREM-1 expression on canine 
neutrophils after exposure to TLR agonists in vitro and in vivo after i.v. LPS 
administration. In vitro, expression of TREM-1 on neutrophils is signifi  cantly 
upregulated by stimulation with microbe-derived agonists against TLR2/6 
(Pam2CSK4), TLR1/2 (Pam3CSK4), and TLR4/MD2 (ultrapure LPS and wildtype 
LPS) (paired t test, P <0.05). The TLR5 agonist fl  agellin did not signifi  cantly 
upregulate TREM-1 expression at any time point. See Figure 1. In contrast, 
i.v. administration of LPS to dogs resulted in a signifi  cant decrease in both 
TREM-1 expression and the percentage of TREM-1-positive neutrophils 
from 6 hours through 12 hours post LPS administration. See Figure 2. The 
disparity between in vitro and in vivo eff  ects of LPS suggest other factors, 
such as systemic and local cytokine production and neutrophil turnover, 
may infl  uence expression and shedding of TREM-1 on canine neutrophils. We 
suggest that naturally occurring sepsis in the dog represents the ideal model 
for defi  ning diagnostic biomarkers and discovering effi   cacious therapeutics 
for use in human sepsis.
Acknowledgements  This presentation was supported by Morris Animal 
Foundation and ICARE.
Figure 1 (abstract P35). Kinetics of TREM-1 expression after TLR agonist 
stimulation in vitro.
Figure 2 (abstract P35). Kinetics of TREM-1 expression post LPS 
administration in vivo.
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Introduction  Older patients comprise an increasing proportion of ICU 
admissions. Advanced age and multiple co-morbidities compromise their 
immunity and hence they may be more prone to succumbing to severe 
infection and have poorer outcome.
Objective To assess the impact of severe sepsis on mortality in the old and 
very old subgroups of patients admitted to a medical ICU.
Methods All patients admitted to a medical ICU of a tertiary care institute 
with severe sepsis or septic shock were prospectively included. Patients were 
divided into young (age below 60 years), old (age between 60 and 80 years), 
and very old (age above 80 years) groups. Data regarding baseline patient 
characteristics, admission APACHE II score, and ICU course including need 
for organ support and ICU length of stay were noted. Qualitative data were 
analyzed using the chi-squared test or Fisher exact test as appropriate and 
quantitative data were analyzed using Student’s t test. Inter-group and intra-
group comparison for quantitative data was done by one-way ANOVA. The 
primary outcome measure was ICU mortality.
Results Of 387 patients who were admitted with signs of SIRS or sepsis 
during the study period of 20 months, 132 patients who fulfi  lled the criteria 
for severe sepsis/septic shock were included in the analysis. The most 
common suspected site of infection was the lungs (60 patients, 45.5%), 
followed by the urinary tract (28 patients, 21.2%) and the abdomen (22 
patients, 16.7%). ICU mortality in younger patients was 45.6% as compared 
with 60.7% in old patients and 78.9% in very old patients (P = 0.035). The 
odds ratio (OR) and relative risk (RR) for dying in the old age group was 1.32 
(95% CI = 0.655 to 2.659) and 1.125, respectively, and OR and RR for dying 
was 3.313 (95% CI = 1.035 to 10.6) and 1.487 in the very old age group. There 
was an increased need for organ support in the old and very old population 
as compared with the younger population. See Table 1.
Conclusions The risk of dying from severe sepsis is considerably higher in 
the old and very old subgroup of patients. Hence, early aggressive care to 
recognize and manage severe sepsis is required to improve outcome.
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Introduction Risk assessments of patients should be based on objective 
variables, such as biological markers that can be measured routinely. 
Such a prediction remains a diffi     cult challenge. The acute response to 
stress causes the release of catecholamines from the chromaffi   n cells of 
the adrenal medulla accompanied by numerous proteins, peptides such 
as chromogranin A (CGA) and its natural fragments. To date, no study has 
evaluated the prognostic value of CGA in critically ill ICU patients.
Methods We conducted a prospective study of ICU patients, admitted for 
a life-threatening condition with at least two organ failures, by measuring 
plasma procalcitonin (PCT), C-reactive protein (CRP), the Simplifi  ed Acute 
Physiological Score II (SAPS II), and CGA on the 24th hour after admission. 
Continuous data are reported as the median (interquartile range), and 
group diff  erences were evaluated with the Mann–Whitney U test or the 
Kruskal–Wallis test. A Cox proportional hazards regression model was used 
to evaluate the eff  ect of the logarithmically transformed CGA concentration 
on the endpoint and to calculate hazard ratios (HRs) with 95% CIs. All 
statistical analyses were performed with the SPSS statistical package (SPSS 
for Windows version 11.5).
Results In 120 consecutive patients, we found positive correlations between 
CGA and the following: CRP (r2 = 0.216; P = 0.02), PCT (r2 = 0.396; P <0.001), 
SAPS II (r2 = 0.438;  P <0.001). Nonsurvivors had signifi  cantly higher CGA 
concentrations than survivors (median (interquartile range): 293 μg/l (163 
to 699 μg/l) vs. 86  μg/l (54 to 175 μg/l), respectively; P <0.001). Serum 
CGA concentrations were signifi   cantly increased in SIRS patients with a 
median value of 115 mg/l (68 to 202), when compared with healthy controls 
(P  <0.001). In cases where infection was associated with SIRS, patients 
had the highest increase in CGA with a median value of 138 mg/l (65 to 
222; P <0.001). See Figure 1. In a multivariable linear regression analysis, 
creatinine (P <0.001), age (P <0.001), and SAPS II (P = 0.002) were the only 
signifi  cant independent variables predicting CGA concentration (r2 = 0.352). 
A multivariate Cox regression analysis identifi  ed three independent factors 
predicting death: log-normalized CGA concentration (hazard ratio (HR), 7.25; 
Figure 1 (abstract P37).
Table 1 (abstract P36)
 Young  Old  Very  old
  (<60 years)  (60 to 80 years)  (>80 years)
Number of patients (n = 132)  57 (43.2%)  56 (42.4%)  19 (14.4%)
Sex, males (%)  36 (63.2%)  38 (67.9%)  10 (52.6%)
Mean age, years (± SD)  44.4 ± 9.8  68 ± 5.4  86.7 ± 5
Mean APACHE II score (± SD)  10.6 ± 6.4  10.5 ± 7.3  13.7 ± 10.1
Inotropic support  51 (89.5%)  45 (80.5%)  16 (84.2%)
Renal support  18 (31.6%)  23 (41.1%)  5 (26.3%)
Mechanical ventilation  33 (57.9%)  41 (73.2%)  16 (84.2%)
Length of ICU stay, days (± SD)  4.56 ± 5.8  4.11 ± 5.4  3.47 ± 2.5
ICU mortality  26 (45.6%)  34 (60.7%)  15 (78.9%)
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1.07), and cardiogenic shock (HR, 3.92; 95% CI, 1.73 to 8.88).
Conclusions The admission plasma CGA concentration is increased in the 
most severe critically ill patients; it correlates with the SAPS II measured after 
24 hours and with infl  ammatory/infectious markers (PCT and CRP). It may 
be useful in establishing an early stratifi  cation for severity in nonselected 
critically ill patients with organ failures.
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Introduction The genus of Chlamydiae  comprises obligate intracellular 
pathogens that occasionally can disseminate and even cause septic 
infections. Chlamydophila pneumoniae causes acute and chronic respiratory 
tract infections from sinusitis to severe pneumonia, and phagocytes can 
transmit the bacteria from the lungs to the vasculature. We have previously 
shown in IL-10 knockout mice that IL-10 limits the severity of infl  ammation 
but prolongs the clearance of the C. pneumoniae pneumonia [1].
Objective Although IL-10 could contribute to the resolution of C. pneumonia 
infection by regulating the T-helper cell balance (Th1/Th2), we were 
interested in the direct eff  ects of IL-10 and the IL-10-regulated genes in 
modulating  C.  pneumoniae  growth in macrophages and in respiratory 
epithelial cells.
Methods  We investigated the eff   ect of IL-10 and the expression of an 
IL-10-responsive anti-infl  ammatory factor on mRNA and protein level in C. 
pneumoniae infected human monocyte/macrophage (MonoMac6 and Thp-
1) and in lung epithelial adenocarcinoma (A549) and in HL (human lung) cell 
lines. We also applied a luciferase promoter assay to study the regulation of 
the anti-infl  ammatory gene expression during the C. pneumoniae infection.
Results In agreement with the previous studies, C. pneumoniae proliferated 
in epithelial cells, while in monocyte/macrophages the infection was 
often nonproductive and aberrant forms of bacteria were observed. The 
IL-10 responsive anti-infl   ammatory factor was diff  erentially  regulated 
at transcriptional level in A549 and MonoMac6 cells in response to C. 
pneumoniae  infection, which could potentially aff   ect the outcome of 
infection. The luciferase promoter assay showed that the transcription was 
mediated via the E-box regulatory element of the gene.
Conclusions  Our results imply that the anti-infl   ammatory response to 
intracellular  C. pneumoniae infection varies in diff   erent cell types and 
ongoing studies are needed to clarify the role of IL-10 response in limiting 
Chlamydia growth in these cells.
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Introduction In a smaller sample of patients with severe sepsis, resuscitation 
with the synthetic colloids hydroxyethyl starch (HES) as well as gelatin (GEL) 
increased the occurrence of acute kidney injury (AKI) in comparison with 
crystalloids (CRYS). We now performed the analysis in a large-scale sample 
with over 1,100 septic patients on our ICU.
Methods A prospective controlled before-and-after study in patients with 
severe sepsis on a mixed ICU. AKI was defi  ned by RIFLE criteria [1]. Statistical 
analysis was performed using SPSS 18.0.
Results  A total of 1,165 patients with severe sepsis were included. At 
baseline, the three groups had similar age, SAPS2 and SOFA scores and 
serum creatinine levels. Between January 2004 and January 2006, patients 
received fl  uid resuscitation with HES (median cumulative dose 81 ml/kg (IQR 
38 to 157), n = 391), mainly as 6% HES 130/0.4 (in 75% of patients) or 10% 
HES 200/0.5. Between February 2006 and March 2008 patients received 4% 
GEL (40 ml/kg (IQR 18 to 71), n = 396), and between April 2008 through April 
2010 patients received only CRYS (n = 387). AKI by any criteria (risk, injury or 
failure) was 34% after CRYS, 55% after HES, and 47% after GEL (P <0.001 for 
HES or GEL vs. CRYS). Renal replacement therapy (RRT) was 28% after CRYS 
compared with 34% after HES (P = 0.04) or 39% after GEL (P = 0.002). Median 
cumulative fl  uid input during ICU stay was 659 ml/kg (IQR 269 to 1,250) after 
HES, 526 ml/kg (IQR 174 to 817) after GEL and 360 ml/kg (IQR 174 to 817) 
after CRYS (P <0.001 HES vs. CRYS, P = 0.003 GEL vs. CRYS). Patients receiving 
synthetic colloids had a signifi  cantly longer median length of stay in the ICU 
(HES: 17 (IQR 8 to 29) days; GEL: 13 (IQR 6 to 24) days vs. CRYS: 11 (IQR 5 to 20) 
days (HES vs. CRYS P <0.001, GEL vs. CRYS P = 0.001)). ICU mortality was 35% 
(HES), 32% (GEL), and 30% (CRYS, P = not signifi  cant).
Conclusions Patients with severe sepsis have a higher risk to develop AKI 
if they receive fl  uid resuscitation with synthetic colloids (HES or gelatin). 
Interestingly, the need for RRT under fl  uid therapy with mainly 6% HES 
130/0.4 was higher than in the VISEP study under therapy with 10% HES 
200/0.5 (RRT: 31.1%, n = 261) [2].
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Introduction  Multiple sclerosis (MS) is an infl  ammatory  demyelinating 
disease of the central nervous system (CNS), the etiology of which is believed 
to have both genetic and environmental components. During recent years, 
attention was paid to the role of bacterial infections in the process of MS 
development. Helicobacter pylori infections have been linked to peripheral 
neuropathies as they may trigger cellular and humoral immunity due to the 
sharing of similar epitopes present in the nervous tissue. We have investigated 
one of the candidate bacterials for the environmental component of MS, 
H. pylori.
Objective To evaluate the roles of H. pylori in tendency toward MS in Iranian 
patients.
Methods In a prospective case–control study, we studied 78 patients with 
MS and 123 healthy controls for viral DNA detection and antibody assay. DNA 
extracted from serum and real-time PCR was employed to detection of H. 
pylori genome. The levels of anti-H. pylori IgG were measured in samples by 
ELISA in Dr Ahmadi’s medical laboratory.
Results We found H. pylori DNA in 84% and 71% of patients and healthy 
controls, respectively. Furthermore, higher levels of anti-H. pylori IgG were 
detected in patients in contrast with healthy controls. Moreover, the genome 
copy number of H. pylori was signifi  cantly increased in patients. Results are 
expressed as the mean ± standard deviation and analyzed using Student’s t 
test for comparison between two groups. Results were considered signifi  cant 
when P <0.05.
Conclusions We did not observe signifi  cant correlation between prevalence 
of H. pylori DNA and development of MS in selected patients, but active H. 
pylori infection was found in patients more than in controls. These results 
support the hypothesis that H. pylori may contribute to the MS disease 
thought to establish active infection process and induce immune response. 
The role of H. pylori in the modulation of MS requires further study.
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Introduction Blood culture is routinely taken at the time of admission to 
the ICU for all patients suspected to have any infection, even though it may 
be positive only in a few patients. Moreover, the impact of a positive blood 
culture in such a patient population is not clear.
Objective To fi nd the incidence of bacteremia at the time of ICU admission, 
to assess its impact on the outcome, and to analyze which factors are related 
to poorer outcomes in these bacteremic patients.
Methods A retrospective cohort study over a 2-year period. Data from all the 
admissions to a medical ICU, in a tertiary care hospital, with suspected infection 
in whom blood cultures were sent at the time of admission were analyzed. 
Data regarding patient demographics, probable source of infection, previous 
antibiotic use, and ICU course were recorded. Severity of illness on admission 
was assessed by APACHE II score. Qualitative data were analyzed using the 
chi-square test or Fisher exact test and quantitative data were analyzed using 
Student’s t test. Primary outcome measure was ICU mortality.
Results A total of 567 patients were included in the analysis. A signifi  cant 
proportion of these patients, 238/567 (42%), were already on antibiotics. 
Three hundred and sixty-three (64%) patients were direct ICU admissions from 
casualty, 61 (10.76%) were shifted from hospital wards, 35 (6.17%) from other 
ICUs in the hospital, and 108 (19.05%) were transfers from other hospitals. 
Blood cultures were positive in only 60/567 patients (10.6%). Mortality was 
signifi  cantly higher in patients with positive blood cultures (27/60, 45% vs. 
69/507, 13.6%; P = 0.000). Univariate analysis for assessing the risk factors for 
ICU mortality among bacteremic patients was done in which age (P = 0.061), 
sex (P = 0.253), type of admission (P = 0.203), type of organism, severity of illness 
(P = 0.234), and site of infection (P = 0.250) were analyzed, but only previous 
antibiotic use was statistically associated with higher mortality (P = 0.011). 
Bacteremic patients who were already on antibiotics had a signifi  cantly higher 
mortality (54.2% vs. 8.3%) (OR 12.9, 95% CI: 1.6 to 100). Mortality was higher in 
patients with Pseudomonas bacteremia (72.7%) although it was not statistically 
signifi  cant (P = 0.08). See Tables 1 and 2.
Conclusions Blood cultures may be positive in only a minority of patients 
with suspected infection admitted to the ICU as most of these patients may 
already be taking antibiotics. Nevertheless, the prognosis of those patients 
with positive blood culture is worse, especially if culture is positive in spite of 
the patient being on antibiotics.
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Introduction  Severe septic syndrome remains one of the most frequent 
causes of death in ICUs. One of the main players in this pathology is the 
endothelium integrity. Our laboratory has demonstrated in preliminary 
clinical studies among the various biomarkers of endothelial dysfunction 
that blood levels of endocan (ESM-1), a pulmonary vascular endothelial 
cell-specifi  c molecule participating in the control of endothelial–leukocyte 
interactions, are associated with the severity and evolution of septic states. 
On the other hand, we showed in vivo that antiprotease therapy is associated 
with a decrease of the leukocyte rolling and fi  rm leukocyte adhesion to 
endothelium in sepsis. This decrease in the leukocyte–endothelial cell 
contacts was associated with an increase of blood endocan levels, suggesting 
a linkage between leukocyte proteases, endocan, and infl  ammation during 
sepsis.
Methods In order to characterize this linkage, we set up a mouse model of 
nonlethal shock induced by endotoxin (LPS), in mice genetically defi  cient 
in cathepsin G (CG–/–) or double defi   cient in cathepsin G and elastase 
(CGEL–/–). The neutrophil and endothelial activation biomarkers included 
myeloperoxidase, sE-selectin, and endocan ELISAs in mouse serum. In vitro 
tests of endocan proteolysis were also performed.
Results  During the nonlethal endotoxemia, clinical scores as well as 
E-selectin levels were maximal at 24 hours and progressively returned to the 
baseline. Circulating myeloperoxidase also increased early at 24 hours but 
remained elevated until 72 hours. By contrast, circulating endocan decreased 
early at day 1, remained undetectable at days 2 and 3, and then normalized 
at day 5. A strong inverse correlation was observed between endocan and 
myeloperoxidase levels. Similar fi   ndings were observed CG–/–. However, 
Table 1 (abstract P41)
  Overall  Blood culture positive  Blood culture negative
 ( n = 567) (n = 60) (n = 507)  P value
Sex, males (%)  332 (58.6%)  41 (68.3%)  291 (57.4%)  0.137
Mean age, years (± SD)  59.2 ± 8.5  59.6 ± 19.4  59.2 ± 18.4  0.859
Mean APACHE II score (± SD)  16.6 ± 8.5  18 ± 9.4  16.5 ± 18.4  0.184
Previous antibiotics  238 (46.9%)  48 (80%)  190 (37.5%)  0.000
Inotropic support  158 (27.9%)  35 (58.3%)  123 (24.3%)  0.000
Renal support  86 (15.2%)  19 (31.7%)  67 (13.2%)  0.000
Mechanical ventilation  164 (28.9%)  34 (56.7%)  130 (25.6%)  0.000
ICU length of stay, days (± SD)  5.4 ± 5.6  5.18 ± 7.4  5.4 ± 5.4  0.782
ICU mortality  96 (16.9%)  27 (45%)  68 (13.4%)  0.000
Table 2 (abstract P41)
  Number of patients  Need for  Need for  Need for 
Organism (n = 60)  inotropes  renal support  mechanical ventilation  ICU mortality
E. coli  27 (45%)  15 (55.6%)  9 (33.3%)  13 (48.1%)  13 (48.1%)
P. aeruginosa  11 (18.3%)  9 (81.8%)  4 (36.4%)  9 (81.8%)  8 (72.7%)
K. pneumoniae  7 (11.7%)  2 (28.6%)  2 (28.6%)  4 (57.1%)  1 (14.3%)
S. aureus  5 (8.3%)  3 (60%)  2 (40%)  2 (40%)  2 (40%)
Others  8 (13.3%)  6 (75%)  2 (25%)  6 (75%)  3 (37.5%)
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in endocan levels. Incubation of mouse endocan with PMN supernatants 
from WT, CG–/–, or CGEL–/– generated a major proteolytic fragment of 14 kDa. 
The proteolytic activity was inhibited by α1-antichemotrypsin.
Conclusions  In nonlethal endotoxemia, both endothelial cells and PMN 
are activated. The kinetics of PMN activation matched with the decrease 
of circulating endocan. In vitro, the PMN-derived serine proteases induce 
endocan cleavage, which may relate to the decrease of circulating level of 
endocan. Our results detail for the fi  rst time the kinetics of endothelial cell 
and PMN activation markers in a mouse model of sepsis and revealed that a 
PMN-derived serine protease is involved in the degradation of endocan that 
diff  ers from CG or EL.
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Introduction  Triggering receptor expressed on myeloid cells-1 (TREM-1) 
and TREM-like transcript 1 (TLT-1) belong to the TREM family. TREM-1 is 
expressed on neutrophils and monocytes/macrophages, and plays a crucial 
role during the onset of sepsis by cooperating with pattern recognition 
receptors in a synergistic way, thus amplifying the host immune response. 
TLT-1 is selectively expressed on activated platelets and is known to facilitate 
platelet aggregation through binding to fi  brinogen. Interestingly, TLT-1 null 
mice displayed higher plasma cytokines concentrations and death rates than 
WT mice during experimental sepsis. We identifi  ed a 17 amino acid peptide 
derived from the extracellular part of TLT-1, named LR17, which is responsible 
for TLT-1 anti-infl  ammatory properties.
Methods To quantify cellular activation, human neutrophils were isolated 
from whole blood by density gradient. After stimulation with LPS, αTREM-1 
(a TREM-1 agonist) and/or LR17, p38-MAPK and ERK1/2 phosphorylation was 
quantifi  ed by western blot; NF-κB activity and cytokine release by ELISA; 
mRNA levels of various gene of interest by quantitative RT-PCR; and ROS 
production by fl  ow cytometry. The eff  ect of siRNA-induced Trem-1 silencing 
was studied on purifi  ed human monocytes. In vivo studies were performed 
on a CLP mouse model of sepsis.
Results αTREM-1-induced or LPS-induced cytokine/chemokine production 
by human neutrophils or monocytes was dose-dependently reduced in the 
presence of recombinant TLT-1 or LR17, both at the gene (mRNA) and protein 
levels (ELISA). This decrease involves a broad set of cytokines and chemokines: 
TNFα, IL-1β, IL-6, IL-8, IL-16, GRO-α, MCP-1, MIP-1β, and RANTES. Exploration 
of intracellular signalling showed that LR17 also reduced αTREM-1-induced 
or LPS-induced p38-MAPK and ERK1/2 phosphorylation, NF-κB activation 
and then ROS production in neutrophils (Figure 1a to e). On Trem-1-silenced 
monocytes, TREM-1 agonist did not induce cytokine production and LR17 
did not show any eff  ect (Figure 1f). As a result of this activity, both early and 
late LR17 administration to septic mice modulated the proinfl  ammatory 
cascade triggered by infection with a decrease of plasma, bronchoalveolar 
lavage and peritoneal fl  uid cytokine concentration, as well as of cytokine 
mRNA levels in the lung and liver. TLT-1 also prevented organ damage and 
coagulation abnormalities and fi  nally improved survival by more than 60% 
versus controls (Figure 2 overleaf).
Conclusions TLT-1 plays a pivotal role during sepsis, linking haemostasis and 
infl  ammation.
P44
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Introduction The use of hydrocortisone (HC) for treatment of septic shock is 
controversially discussed. Microarray data from the CORTICUS trial showed 
the transcript encoding monoamino-oxidase-A (MAOA) as one of the 
Figure 1 (abstract P43). LR17 decreases LPS-associated and αTREM-1-associated human neutrophil activation.
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oxygen species (ROS) and apoptosis, MAOA might play an important role in 
infection and development of organ dysfunction in these patients. Blocking 
MAOA with the specifi  c inhibitor clorgylin (CL) may provide a new therapeutic 
intervention for sepsis. The present study investigates the function of MAOA 
in sepsis and the potential benefi  ts of its inhibition.
Methods  A total of 15 patients with severe sepsis or septic shock were 
enrolled and compared with 10 healthy controls. As a polymicrobial sepsis 
model, 16-week-old C57BL6 mice were injected intraperitoneally with 5 μg/g 
BW characterized human feces. Animals were treated once a day with 35 ml/
kg BW saline and 4 mg/kg BW HC + 0.25 mg/kg BW CL. MAOA mRNA was 
quantifi  ed by quantitative PCR, and protein levels were measured by fl  ow 
cytometry. Phagotests determining phagocytotic activity were performed 
following the manufacturer’s instructions. For ex vivo stimulation, whole 
blood of healthy individuals was incubated with HC (50 μg/ml) and LPS 
(100 ng/ml). For labora  tory and microbiological analyses, routine laboratory 
procedures were used. ROS were measured by difl  uorodihydrofl  uorescein 
diacetate and fl  ow cytometry.
Results  Quantitative PCR showed a signifi  cant increase of MAOA mRNA 
expression in patients with sepsis versus healthy controls (eightfold, P <0.05). 
The same is true for protein levels of MAOA (1.5-fold, P <0.05). Blocking of 
MAOA by CL enhanced phagocytosis ex vivo (140%, P <0.05). In the animal 
model after MAOA inhibition, the survival rate was signifi  cantly higher (risk 
reduction 40%, P <0.05) and less bacterial burden was found in the blood, 
lung, and liver (1 log, P <0.05). Furthermore, less organ damage shown by 
LDH, ASAT and ALAT was observed (P <0.05). These results were associated 
with less ROS production in granulocytes (P <0.05).
Conclusions MAOA is strongly upregulated during severe sepsis on RNA as 
well as on protein level. In septic mice, higher survival rates were observed 
by blocking MAOA. Inhibition of MAOA might have potential in sepsis and so 
provide a novel method for therapeutic intervention.
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Introduction In sepsis, the severity-dependent decrease of the VWF-cleaving 
protease ADAMTS13 is a common phenomenon, which may contribute to 
aggregation of platelets/platelet consumption and the development of 
sepsis-associated thrombotic microangiopathy (TMA) and organ failure. Up 
to now, hepatic stellate cells (HSC) are considered to function as the primary 
source of ADAMTS13 protein. The underlying mechanisms of the decrease in 
sepsis remain unclear.
Methods We present data obtained in in vitro experiments using cultured 
human HSC (LX2-line) and microvascular endothelial cells (HMEC) stimulated 
under proinfl  ammatory conditions. Monolayers were exposed to cytokines 
known to be plasma abundant/relevant during systemic infl  ammation (TNF, 
IL1β, IFNγ), to bacterial endotoxin (100 ng/ml), to a mixture of cytokines/
endotoxin, or to freshly prepared serum obtained from patients (n = 12) with 
severe sepsis/septic shock.
Results Both cell lines expressed ADAMTS13 mRNA as quantitated using 
quantitative PCR normalized to a set of unvaried genes. Overall, incubation 
with cytokines resulted in a decrease of ADAMTS13 mRNA to diff  erent extents 
ranging between 40 and 80% of the basal transcription rate in between 
24 hours. Furthermore, in endotoxin-treated cells, ADAMTS13 declined to 
60% (HSC) or 65% of basal levels. This eff  ect was more pronounced by the 
mixture of cytokines/endotoxin to levels of 55% (HSC) or 40% (HMEC). In 
monolayers treated with serum from patients with sepsis, only 10% (HSC) 
or 49% (HMEC) of the basal level was determined. Both the trace element 
selenium and activated protein C, which are used in the supportive therapy 
of patients with sepsis, ameliorates the decrease in serum-treated HSC and 
increased the level of ADAMTS13 transcript in endothelial cells. Continuous 
infusion adapted to body weight also abolished the decrease of ADAMTS13 
expression in hepatic tissues during the course of polymicrobial sepsis in 
mice.
Conclusions We found that mRNA coding ADAMTS13 protein is also present 
in endothelial cells. Also we observed a marked decrease in both cell lines 
undergoing proinfl  ammatory stimulation. This mechanism may contribute 
to the decline of proteolytic activity of ADAMTS13 in patients with sepsis 
and sepsis-associated TMA. Furthermore, the amelioration of this eff  ect 
by selenate and APC may function as mechanisms resulting in the more 
favorable outcome observed in a number of clinical studies.
Acknowledgements Funding by the German Research Council (DFG CL 
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Introduction  In lethal polymicrobial sepsis, toll-like receptor 4 (TLR-4) 
mediates a critical role in impeding the migration of neutrophils to infectious 
Figure 2 (abstract P43). LR17 protects mice from caecal ligation and puncture (CLP)-induced mortality. (a) Dose–response curves. (b) Delayed LR17 administration.
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mortality. We have previously shown that the selective gastrin-releasing 
peptide receptor antagonist RC-3095 can reduce organ dysfunction in 
experimental sepsis. Thus the aim of the present study is to report a novel link 
between GRPR and TLR-4 signaling and its relationship with infl  ammatory 
parameters in in vitro and in vivo experimental models as well as in sepsis 
patients.
Methods  For the in vitro experiment, RAW 264.7 macrophages were 
stimulated with LPS and treated with RC-3095 for RT-PCR analyses of TLR-
4 mRNA, immunoblotting of pERK1/2, pJNK, pAkt, and EMSA of NF-κB 
and activator protein 1 (AP-1). In the in vivo studies, male Wistar rats were 
divided and submitted, into sham surgery, cecal ligation and puncture (CLP) 
surgery, and CLP plus RC-3095. Six hours after, all rats were anesthetized 
and sacrifi  ced by cardiac puncture. Blood was collected for bacterial count 
and cytokine analyses; bronchoalveolar lavage fl  uid for cell count, levels of 
TLR-4 and cytokines; peritoneal lavages for bacterial count; and lung tissue 
for levels of TLR-4 and RT-PCR analyses of TLR-4 mRNA. In a human study 12 
patients, admitted to an adult medical ICU with a clinical diagnosis of septic 
shock, received a continuous infusion with RC-3095 over a period of 12 hours 
and concentrations of IL-6 and IL-10 in plasma were determined. Results are 
expressed as means ± SD. Diff  erences between groups were determined by 
ANOVA, followed by Tukey’s post hoc test. Diff  erences between two groups 
were determined by t test.
Results RC-3095 inhibited expression of TLR-4 and reduced phosphorylation 
of extracellular signal-regulated kinase (ERK-1/2), c-Jun NH2-terminal 
kinase (JNK), and Akt, leading to decreased activation of NF-κB and AP-1 in 
macrophages. In a rat model of sepsis, RC-3095 treatment decreased lung 
TLR-4 content, reduced the migration of infl  ammatory cells to the lung, 
reduced systemic cytokine levels, and attenuated bacterial dissemination. 
Continuous infusion with RC-3095 for 12 hours decreased IL-6 plasma levels 
in septic patients, but did not signifi  cantly aff  ect IL-10 plasma levels.
Conclusions  These fi   ndings demonstrate the benefi   cial action of GRPR 
antagonists in controlling the infl  ammatory response in sepsis through a 
mechanism involving inhibition of TLR-4 signaling.
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Generation of bioactive lipids such as ceramide (Cer) and the formation 
of Cer-enriched macrodomains are regarded as mediators of SIRS and the 
development of multiple organ failure. Therefore, we addressed the question 
of whether there is a diff  erence in the plasma activity of the secreted isoform 
of the Cer-forming enzyme sphingomyelinase (SMPD1) in patients with 
various degrees of SIRS/sepsis of diff  erent origin as well as in a murine 
loss of function model. We found plasma activity in critically ill patients 
(median 262.3 pmol/ml*hour) was signifi  cantly higher than age-matched 
controls (123.6). In patients with fatal outcome, activity increased (+77.4) 
in comparison with survivors (–252.1). A severity-dependent increase was 
also analyzed in patients with multiple organ dysfunction syndrome (MODS) 
following elective cardiac surgery. Beyond immunological detection of 
increased pSMPD1 in septic patients, we found an increase in Cer-enriched 
macrodomains in endothelial cells after stimulation with patients’ plasma, 
endotoxin, or TNF.
We also found formation of Cer-enriched macrodomains by immunostaining 
using specifi  c antibodies directed against Cer, CD14, and Fas. In a loss of 
function model, we identifi   ed 315 transcripts diff   erentially regulated in 
circulating white blood cells, liver, and lung by use of microarray technology 
as well as in the cytokine pattern/organ function parameters following 
polymicrobial cavity infection. Furthermore, host responses in knockout 
mice were more pronounced with respect to bacterial load in lung, liver, 
and blood, plasma cytokine levels, thrombocytopenia as well as delayed 
migration of neutrophils into hepatic tissue.
In conclusion, the results provide demonstration of a biofunctional relevant 
activity of SMPD1 resulting in altered signal transduction in SIRS, which may 
contribute to the development of MODS.
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Introduction  Having the ability to predict organ failure could impact 
treatment decisions and potentially lessen the consequences of acute lung 
injury (ALI) and sepsis. While Acute Physiology and Chronic Health Evaluation 
(APACHE II) and the Pneumonia Severity Index are useful in predicting the 
risk of morbidity and mortality, they do not predict the risk of developing 
organ failure. Currently no accepted practice allows for the prediction of the 
development of organ failure. The objective, therefore, of our study was to 
predict the development of organ failure at 24 hours using only the data 
available from the fi  rst 4 hours post inoculation.
Methods  This pneumonia-sepsis model included 19 sheep with ALI. 
Inoculation of ~2.5 × 1011 colony-forming units methicillin-resistant 
Staphylococcus aureus (MRSA) induced pneumonia, while smoke injury was 
created through inhalation of cotton smoke. Four diff  erent groups were 
studied and are as follows: MRSA and smoke inhalation (M+S, n = 7), MRSA 
untreated (M, n = 3), MRSA treated (M+T, n = 3), and smoke inhalation only (S, 
n = 6). In order to use the injury group as a model input, all the sheep were 
modeled independent of group and a rank order of severity was determined. 
Additional inputs included a number of clinical and laboratory parameters. 
Only the fi  rst 4 hours of data were allowed to be used as an input. The model 
outputs were prothrombin time (PT) and mean arterial pressure (MAP) over 
the entire 24-hour time frame. To minimize overparameterization, only two 
inputs per output were used for prediction.
Results The rank order of injury group from least to greatest severity was 
M+T, S, M, M+S. PT was best predicted by calcium and injury. The agreement 
between predicted and measured PT using only calcium as the input was 
r2 = 0.24. Adding the second input, in this case injury group, improved the 
model’s predictive ability (r2  =  0.48). MAP was best predicted by lactate 
with an agreement between predicted and measured of r2 = 0.64. Unlike 
PT, the model was not able to better predict MAP by adding a second input 
(r2 = 0.64).
Conclusions Our model was able to provide an accurate prediction of MAP 
using only the fi  rst 4 hours of data, while PT was less accurately predicted. 
However, this early study suggests that continued refi   nement of the 
progression model could provide a viable tool to predict organ failure in 
sepsis.
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Introduction  Methicillin-resistant  Staphylococcus aureus (MRSA) is an 
invasive pathogen in critically ill patients, and is commonly the cause of 
nosocomial pneumonia. Infection with MRSA can lead to bacteremia, septic 
shock, and multisystem dysfunction. Previous work has demonstrated that a 
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sepsis. In the present study, we sought to combine sheep and clinical data 
from humans to determine whether common parameters existed across 
sepsis with regard to coagulopathy. Secondly, we wanted to model and 
provide estimates of MRSA bacterial load in both species.
Methods Nineteen sheep with acute lung injury and 14 human patients 
were incorporated into this sepsis model. In sheep, pneumonia was induced 
by inoculating the airway with ~2.5 × 1011 colony-forming units (CFU) 
MRSA. Thirteen of the sheep had smoke injury induced through inhalation 
of cotton smoke. All human patients were retrospectively studied and 
were bacteremic with MRSA from varying primary infection sites. Initial 
bacterial load in humans was modeled using clinical and microbiologic 
data available at the start of sepsis, while the initial load in sheep was the 
inoculating amount of bacteria. Load continues throughout the study period 
and is modifi  ed by vital signs and antibiotic coverage. The bacterial load as well 
as clinical and laboratory parameters are inputs, with the output parameter 
being prothrombin time (PT). In order to minimize overparameterization 
of the population, the model was allowed to estimate PT using only three 
parameters. Data were modeled for 24 to 48 hours.
Results Bacterial load was estimated to range from between 108 and 1011 CFU, 
with the high end of the range being similar to the inoculum used to induce 
pneumonia in the sheep. The highest-ranking parameters in estimating PT 
were calcium, potassium, and bacterial load. When using calcium alone, 
the model estimate agreement with measured PT was r2 = 0.25. Combining 
calcium and potassium improved agreement (r2 = 0.34), while using all three 
parameters further improved the estimate (r2 = 0.37).
Conclusions  Through progression modeling we were able to provide 
prediction of coagulopathy and bacterial load across two diff  erent species of 
animals infected with the same organism.
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Understanding the mechanisms of bacterial immune modulation will teach 
us more about pathogenesis of infection and could lead to new strategies 
in anti-infl  ammatory therapy during sepsis. Various approaches are already 
used to identify bacterial immune modulating proteins. However, these 
are ineffi   cient and time consuming. Immune modulating proteins need to 
be secreted in order to act on their targets outside the bacterial cell. In the 
present study, phage display technology was used to specifi  cally identify 
secreted immune modulating proteins with high effi   cacy.
Phage display technology is a technique to express a protein fused to a coat 
protein of a fi  lamentous phage. The most widely used coat protein is pIII 
encoded in the phage genome by gIII. This gene contains a signal sequence 
that is essential for production of stable phage particles. When a bacterial 
genome is randomly fragmented and these fragments are inserted into 
a phage vector containing gIII lacking the signal sequence, intact phage 
particles are formed only when the inserted bacterial genomic fragment 
contains a signal sequence. This allows for selective expression of a bacterial 
secretome since secreted proteins also contain a signal sequence. The 
resulting secretome phage library can be used to select displayed proteins 
that specifi  cally bind to various components of the immune system. This 
powerful technique has several advantages: it can be used for diff  erent 
Gram-positive and Gram-negative bacterial genomes. There is no need for 
extensive culturing of bacteria so it can be used for diffi   cult or slow-growing 
bacteria. Expressed proteins are not hampered by solubility problems.
There is a direct relation between expressed protein and coding gene that 
allows for rapid identifi  cation of selected proteins. As a proof of principle, 
a Staphylococcus aureus library was constructed. The goal is to evaluate the 
proportion of previously described secreted immune modulators that can 
be recovered and to identify new immune modulators. In order to express 
most of the 300 secreted proteins encoded by this microorganism, the library 
reached a diversity of 108 clones. The secretome phage library was screened 
for interaction with leukocytes and for modulation of the coagulation and 
complement pathways, which are highly activated in sepsis process.
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Introduction Healthcare-associated infection (HAI) control is one of the most 
important challenges in quality and safety. Defi  ned as the intensive use of the 
information and communication technologies, e-health can be a major part 
of this matter. Aiming for implementation of an infection control strategy 
based on the e-health concept in a 280-bed, paper-free, general hospital, the 
Infection Control Committee (ICC), along with the Quality and Antibiotics 
Committees and the IT team, has been working on the implementation of 
new tools for widespread use.
Methods The authors used the electronic medical record, a special program 
for infection surveillance and data-mining, and some additional resources, 
such as messages and alerts sent by email or by SMS, as a global approach 
for improving infection control. On the electronic medical record (Soarian®; 
Siemens Medical Solutions), interventions are made at diff  erent levels. On 
patient admission, through the fulfi  llment by the physician of a questionnaire 
on detection of increased risk for infection/colonization, several protocols 
regarding isolation and screening testing are automatically activated and the 
ICC is informed via email, thus minimizing the spread of epidemiologically 
important microorganisms. During hospitalization, new templates for 
prescribing microbiological tests are in progress to improve the availability 
of clinical information to the laboratory and to the Vigiguard® (Biomérieux) 
program. New context-sensitive templates for antimicrobial prescription are 
being implemented to improve the quality of such therapeutics. Alerts to 
the pharmacy are sent when there is some inaccuracy in terms of the chosen 
antimicrobial or the duration of therapy, thus reducing the emergence of new 
drug resistances and minimizing costs. New fi  elds were created to individualize 
infection control issues in the patient’s history, and to generate an automatic 
note on epidemiologically important issues at the transfer or discharge of the 
patient, thus complying with the recommendations for information transfer. 
Finally, surveillance of several infections/colonizations will be obtained in real 
time from Vigiguard®, a tool with a data-mining engine.
Conclusions The authors hope that the application of the e-health concept 
to the infection control policy in a paper-free hospital will improve quality of 
and reduce the risk of HAI.
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Introduction As has been seen in several studies, many authors describe 
details of diff   erent cytokines’ elimination from blood serum by carbon 
sorbents. Some data have been published about carbon immobilization of 
cytokines bounded and nonbounded in complexes with specifi  c cytokine 
receptors. The aim of the present study was to research cytokine and soluble 
cytokine receptor elimination by carbon sorbents from blood.
Methods The blood samples from 28 cancer patients with sepsis before and 
after extracorporeal detoxifi  cation by Adsorba 300C (Gambro, Sweden) were 
analyzed. The sorbent washouts were also tested. We evaluated cytokine 
levels (IL-1β, IL-6, TNFβ) and their soluble receptors (sIL-1RII, sIL-6R, sTNFRI) 
in the samples.
Results Our experiments showed that, after hemoperfusion, the cytokine 
levels in blood decreased or did not change compared with the initial 
cytokine level. At the same time the soluble cytokine receptor level increased 
considerably after the procedure (from 1.7 to 2.6 times). The cytokine level 
in the sorbent washouts was also very high. Therefore, the soluble receptor 
level was lower in the washouts than in the serum.
Conclusions These results can partially be explained by the ability of carbon 
sorbent to eliminate cytokine molecules more actively than cytokine 
receptors. Therefore, it is tempting to suppose that carbon hemosorption 
leads to a considerable reduction of serum cytokines, bounded and soluble, 
but preserves the soluble receptors. These peptide molecules play an 
important role in the formation of adequate anti-infl  ammatory response.
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Introduction Successful clearance of bacterial infection depends on effi   cient 
neutrophil migration to infected tissues [1]. Chemotaxis is a crucial event 
for neutrophil migration to local infection and is controlled mainly through 
activation of G-protein-coupled receptors. Furthermore, the functionality 
of these receptors is regulated by G-protein-coupled receptor kinases 
(GRKs) [1]. Impaired chemotactic responses in sepsis was correlated with 
dysregulated neutrophil toll-like receptor (TLR) signaling, TLR2 and TLR4, 
while TLR9 inhibition in dendritic cells was associated with reduction of 
mortality in polymicrobial sepsis [2]. Despite the TLR9 expression, the role 
of this receptor in neutrophil chemotaxis has not been studied. Thus, the 
aim of the present study was to verify the importance of TLR9 activation on 
neutrophil migration during sepsis.
Methods C57BL/6 wildtype (WT) and TLR9–/– mice were submitted to the 
cecal ligation and puncture (CLP) sepsis model and the survival rate was 
evaluated over 7 days. Also, neutrophil migration to the peritoneal cavity was 
measured 6 hours after CLP. Chemotaxis of blood neutrophils to CXCL2 in the 
Boyden camera, CXCR2 expression, and GRK2 induction on blood neutrophils, 
measured by fl  ow cytometry and immunofl  uorescence, respectively, were 
performed 2 hours after CLP. All experiments were developed in accordance 
with the ethical guidelines of the School of Medicine of Ribeirão Preto, 
University of São Paulo (protocol number 150/2009).
Results TLR9–/– mice submitted to CLP had an enhanced survival rate when 
compared with WT mice (P = 0.096), and these knockout mice had increased 
the neutrophil migration to infectious focus (P  =  0.0445). Investigating 
the mechanism by which the defi  ciency of TLR9 could recover neutrophil 
migration, it was observed that neutrophil derived from TLR9–/– CLP-treated 
mice had restored the ability to migrate in vitro (chemotact assay) toward 
MIP-2, CXCR2 ligand (P  =  0.0133). Moreover, the recovery in neutrophil 
chemotaxis was associated with an enhancement in CXCR2 expression on 
the neutrophil surface and a reduction in GRK2 induction.
Conclusions In sepsis, TLR9 activation, similar to that previously observed 
with TLR2 and TLR4, can also be harmful to control bacterial growth, because 
it impairs neutrophils from reaching the infection focus.
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Introduction  Evidence from our laboratory has shown alterations in 
myocardial structure in severe sepsis/septic shock. The morphological 
alterations are heralded by sarcolemmal damage, characterized by increased 
plasma membrane permeability caused by oxidative damage to lipids and 
proteins. The critical importance of the dystrophin–glycoprotein complex 
(DGC) in maintaining sarcolemmal stability led us to hypothesize that loss of 
dystrophin and associated glycoproteins could be involved in early increased 
sarcolemmal permeability in experimentally induced septic cardiomyopathy.
Methods and results Male C57Bl/6 mice were subjected to sham operation 
and moderate (MSI) or severe (SSI) septic injury induced by cecal ligation 
and puncture (CLP). Using western blot and immunofl  uorescence,  a 
downregulation of dystrophin and β-dystroglycan expression in both 
severe and moderate injury could be observed in septic hearts. The 
immunofl   uorescent and protein amount expressions of laminin-α2 were 
similar in SSI and sham-operated hearts. Consonantly, the evaluation of 
plasma membrane permeability by intracellular albumin staining provided 
evidence of severe injury of the sarcolemma in SSI hearts, whereas 
antioxidant treatment signifi   cantly attenuated the loss of sarcolemmal 
dystrophin expression and the increased membrane permeability.
Conclusions The present study off  ers novel and mechanistic data to clarify 
subcellular events in the pathogenesis of cardiac dysfunction in severe 
sepsis. The main fi  nding was that severe sepsis leads to a marked reduction 
in membrane localization of dystrophin and β-dystroglycan in septic 
cardiomyocytes, a process that may constitute a structural basis of sepsis-
induced cardiac depression. In addition, increased sarcolemmal permeability 
suggests functional impairment of the DGC complex in cardiac myofi  bers. 
In vivo observation that antioxidant treatment signifi  cantly abrogated the 
loss of dystrophin expression and plasma membrane increased permeability 
supports the hypothesis that oxidative damage may mediate the loss of 
dystrophin and β-dystroglycan in septic mice. These abnormal parameters 
emerge as therapeutic targets, and their modulation may provide benefi  cial 
eff  ects on future cardiovascular outcomes and mortality in sepsis.
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Introduction One of the main players in the severity of sepsis is the 
endothelium integrity. Endocan, also called endothelial cell-specifi  c 
molecule-1 (ESM-1), was shown to be preferentially expressed in lung 
vasculature. Structurally, endocan/ESM-1 is a 50 kDa proteoglycan that 
can interact with ICAM-1 and LFA-1 integrins and consequently prevents 
infl  ammatory events. In an experimental rat endotoxemic shock model, we 
previously showed that a decrease in the leukocyte–endothelial cell contacts 
(induced by drugs) is clearly linked to an increase of blood endocan levels. 
Blood levels of endocan/ESM-1 were also shown to be associated with the 
severity and evolution of septic states in preliminary studies.
Methods  We have designed a prospective observational larger clinical 
study with 125 septic patients recruited to assess endocan/ESM-1 blood 
levels concomitantly with a comparison with survival at D10, severity score 
(SAPS II) at D2 and D7, and other biomarkers such as procalcitonin, CRP, and 
interleukins. ICU patients were followed over a 28-day period. Time course 
kinetics of serum endocan/ESM-1 at D0, D2, and D7 were performed using 
an ELISA assay (EndoMark H1; Lunginnov).
Results Our preliminary results for 39 patients showed that endocan/ESM-1 
blood levels were increased at ICU admission in patients with poor prognosis 
(severe sepsis and septic shock). The monitoring of plasma endocan/ESM-1 at 
D2 and D7 revealed sustained elevated endocan levels in patients deceased 
within D10 (n = 12). By contrast, the endocan levels fall down as early as D2 in 
patients who survived at D10 (n = 27). Among the other molecules evaluated 
in this study, only anti-infl  ammatory IL-10 presented similar variations to 
endocan/ESM-1. These results suggest that both endocan/ESM-1 and IL-10 
may have potent predictive values for patient follow up.
Conclusions We have demonstrated that a simple, accurate, and blood-based 
biomarker such as endocan/ESM-1 (EndoMark H1; Lunginnov) could assess 
the initial severity and closely follow the infl  ammatory events and endothelial 
dysfunction in patients, and therefore would be hugely helpful for clinicians to 
predict outcome and to select more appropriate therapeutic strategies.
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Introduction Crimean-Congo hemorrhagic fever (CCHF) is a viral zoonotic 
disease with up to 50% mortality rate in humans and belongs to the Nairovirus 
genus and Bunyaviridae family. CCHF manifests with four distinct phases 
including incubation, prehemorrhagic, hemorrhagic, and convalescence. 
The virus is transmitted to humans by infected tick bite, handling of infected 
blood or tissues, or nosocomially. In the present study, serological and 
molecular epidemiology of CCHF infection was surveyed among the Iranian 
population during the past decade.
Methods  From 2000 to 2010 (30 May), probable sera of the human 
population throughout the country were collected. Then, the sera were 
analyzed through serological (IgM and IgG specifi  c ELISA) and molecular 
(gel-based and real-time RT-PCR) testing.
Results As the results show, among 1,377 human probable sera collected 
from diff  erent parts of the country, 544 human cases were confi  rmed for 
CCHF and 79 CCHF death cases were reported to date. Sistan and Baluchistan 
(383 confi  rmed cases), Isfahan (44), Fars (26), Tehran (17), and Khorasan (12) 
were the most infected provinces, respectively. Slaughterers, butchers, 
and farmers, with 21.6%, 17.64%, and 17.46%, ranked the highest among 
professions, respectively. Also, 52.2% of confi  rmed cases were in an age 
range of 21 to 40 years and, interestingly, CCHF infection was shown in males 
(77.5%) more than females (22.5%).
Conclusions Although CCHF has been confi  rmed in 23 out of 30 provinces 
of Iran, the disease has occurred with the highest grade in Sistan and 
Baluchistan during the past decade, certainly because of its proximity to 
Pakistan and Afghanistan, two countries with endemic CCHF. In the present 
study, it was demonstrated that CCHF was seen much more in the active 
age range and is more common in high-risk professions related to livestock 
such as butchers, slaughterers, and farmers. Therefore, it seems, informing 
the groups of high-risk professions has been effi   cient. Fortunately, with 
precise surveillance and laboratory detection, the mortality rate has been 
remarkably decreased recently.
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